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- ABSTRACT 
The work in this Thesis explores the role of different diagnostic imaging 
techniques in the characterization and early diagnosis of Spondyloarthritis and Psoriatic 
Arthritis and studies imaging and clinical indicators of prognosis in these diseases. 
 
First, we studied the prevalence of bone marrow oedema on magnetic resonance 
imaging (MRI) in patients with axial Psoriatic Arthritis compared to patients with non-
radiographic axial Spondyloarthritis and Ankylosing Spondylitis in relation to HLA-
B27 status. In this study, it was shown that patients with Psoriatic Arthritis who were 
HLA-B27 positive had a comparable amount of inflammatory burden to patients with 
Ankylosing Spondylitis. 
 
Using ultrasound, several studies were performed in relation to the enthesis.  
Firstly, focused in the ultrasound assessment of the retro-calcaneal bursa at the Aquilles 
enthesis showing that this is a commonly affected entheseal site in early 
Spondyloarthritis when compared to healthy individuals. Secondly, we demonstrated 
the utility of Doppler ultrasound in the assessment of disease activity in patients with 
early Spondyloarthritis and as an objective outcome measure for enthesitis. Finally, we 
explored the role of ultrasound in the assessment of the sacroiliac joints in patients with 
Spondyloarthritis, demonstrating its usefulness in the detection of active sacroiliitis. 
 
Nail involvement in psoriasis is associated with functional impairment. In this 
part of the Thesis, we explored the possible link of the nail and the underlying enthesis 
in two studies involving subjects affected with psoriasis and Psoriatic Arthritis. In the 
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first study, using high resolution ultrasound, the link between the extensor tendon and 
the nail, as well as the importance of enthesopathy associated with nail involvement, 
regardless of the presence of arthritis, are demonstrated. In the second study, optic 
coherence tomography (OCT), a novel non-invasive imaging technique without 
irradiation was used in addition to ultrasound to characterize nail involvement in 
psoriasis and Psoriatic Arthritis showing that OCT is a promising tool for the systematic 
characterization of psoriatic nail changes and suggesting its possible role as a diagnostic 
and outcome measure. 
 
In the final part of this work, we sought to identify predictors of prognosis in 
patients with Psoriatic Arthritis and Spondyloarthritis. For this purpose, we evaluated 
the enthesis of patients with Psoriatic Arthritis and patients with psoriasis, all 
asymptomatic. We observed more inflammation in patients with psoriatic arthritis, 
which may help to understand the progression of the disease from the skin to the joint. 
Finally, we explored the long term outcome of a cohort of early oligoarthritis in which 
an early treatment intervention was performed, finding that at 10 years a third of 
subjects were in drug-free remission. 
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- RESUMEN 
En esta tesis doctoral estudiamos diferentes técnicas de imagen para el 
diagnóstico y la caracterización de las Espondiloartritis y de la artritis psoriásica, así 
como para su diagnóstico precoz. Además, se estudian también diferentes indicadores 
clínicos y de imagen para poder conocer el pronóstico de estas enfermedades.  
En el primer lugar estudiamos la prevalencia de edema óseo en resonancia 
magnética en pacientes con artritis psoriásica axial comparado con pacientes con 
Espondiloartritis axial no radiográfica y Espondilitis Anquilosante en relación al estatus 
del HLA-B27. En este estudio se demostró que los pacientes con artritis psoriásica que 
eran HLA-B27 positivo tenían una afectación inflamatoria comparable a de los 
pacientes con Espondilitis Anquilosante. 
En cuanto a ecografía, hemos realizado varios trabajos en relación a la entesis. 
En primer lugar hemos estudiado la valoración ecográfica de la bursa retrocalcánea de 
la entesis aquilea en la Espondiloartritis precoz, demostrando que es una localización 
frecuentemente afectada en estos pacientes. En segundo lugar, hemos demostrado la 
utilidad de la ecografía en la valoración de la actividad de la enfermedad en pacientes 
con Espondiloartritis precoz y como medida objetiva de actividad de entesitis. 
Finalmente, hemos explorado ecográficamente las articulaciones sacroilíacas de 
pacientes con Espondiloartritis, demostrando su utilidad en la detección de sacroileítis 
activa.  
La afectación ungueal en la psoriasis está asociada con discapacidad funcional. 
En esta parte de la tesis hemos investigado el posible vínculo ente la uña y la entesis 
subyacente en dos estudios en los que se incluyen pacientes con psoriasis cutánea y 
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pacientes con artritis psoriásica. En el primer estudio se demuestra el vínculo existente 
entre la entesis del tendón extensor y la uña, así como la importancia de la entesopatía 
asociada a afectación ungueal, independientemente de la presencia de artritis, utilizando 
la ecografía de alta resolución. En el segundo utilizamos, además de la ecografía, la 
tomografía de coherencia óptica, una novedosa técnica de diagnóstico por imagen no 
invasiva y sin irradiación. Los hallazgos son prometedores como técnica para la 
caracterización de las lesiones ungueales de los pacientes con psoriasis y sugieren su 
posible papel como técnica de diagnóstico y de medida de desenlace.  
Como parte final de esta Tesis, hemos intentado identificar factores predictivos 
de la enfermedad en pacientes con Artritis Psoriásica y Espondiloartritis. Para ello 
valoramos ecográficamente la entesis de pacientes con artritis psoriásica y de pacientes 
con psoriasis, todos ellos asintomáticos. Observamos más inflamación en los pacientes 
con artritis psoriásica, lo cual podría ayudar a entender la progresión de la afectación 
cutánea a la articular. Finalmente hemos analizado los resultados de seguimiento de una 
Cohorte de Oligoartritis en los que se realizó una intervención precoz, encontrándose 
que a los 10 años un tercio de ellos se mantienen en remisión y sin tratamiento.  
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1. INTRODUCTION 
 
1.1 . Imaging Diagnostic Techniques in Spondyloarthritis and 
Psoriatic Arthritis 
1.1.1.  MRI in the assessment of axial Psoriatic Arthritis and 
Spondyloarthritis 
 
Psoriatic arthritis (PsA) is a heterogeneous disease with a variable, sometimes 
evolving clinical phenotype. An estimated 25–70% of patients may have spinal 
involvement, which varies from largely asymptomatic to severe inflammatory back 
pain, that may be indistinguishable from ankylosing spondylitis (AS). It is sometimes 
difficult to establish the presence of inflammatory back pain in patients with PsA, who 
generally report less  pain than patients with AS (1). Previous studies have 
demonstrated that AS differs from axial PsA radiographically, with the latter having 
some distinctive features such as asymmetry, less severe structural damage, and 
distinctive syndesmophytes (2). The utility of magnetic resonance imaging (MRI) in the 
diagnosis and assessment of spinal disease in AS and non-radiographic axial SpA is 
now well proven (3). However, data are sparse on spinal MRI in non-radiographic axial 
SpA, and it is unclear whether MRI appearances of spinal involvement differ between 
patients with nonradiographic axial SpA or AS and patients with PsA-related 
spondylitis (4).  
 
HLA–B27 shows a striking relationship with AS and is associated with the 
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severity of MRI-evident osteitis in the axial and peripheral skeleton (5-7). In patients 
with early inflammatory back pain, a combination of severe sacroiliitis and HLA–B27 
has a high specificity for the future development of AS. In contrast, there is a very low 
likelihood that AS will develop in patients with mild or no osteitis, regardless of HLA–
B27 status (8). It is also known that positive MRI findings at baseline in patients with 
early inflammatory back pain predict positive MRI findings during followup in HLA–
B27–positive patients (9). However, it is unclear whether such a relationship between 
HLA–B27 and inflammation can be seen on the spine and sacroiliac (SI) joint MRI of 
PsA patients. 
 
1.2. Ultrasound in Spondyloarthritis and Psoriatic Arthritis 
1.2.1. Ultrasonography of the Achilles bursa in early 
Spondyloarthritis 
 
The diagnosis of SpA is often made several years after the disease begins. The 
absence of both radiographic sacroiliitis and impaired spinal mobility at early stages of 
the disease contributes to the long delay (5–10 years) in the diagnosis of AS in many 
patients.  
 
Enthesitis, inflammatory involvement of the enthesis, is a distinctive feature of 
SpA regarded as the primary lesion in this disease. The central importance of the 
enthesis in understanding SpA pathophysiology has remerged in the last decade relating 
structural entheseal damage with inflammation, regional microanatomy and 
biomechanics, and its correlation with entheseal new bone formation, and erosion (10-
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13). Considering the cardinal role of enthesis inflammation on SpA and the striking 
finding that clinical examination lacks sensitivity and specificity, as has been 
demonstrated by several studies comparing clinical evaluations with new imaging 
techniques such as ultrasound (US) (14-16), it is fundamental to study and define the 
elemental lesions that build the concept of enthesitis. Over the last few years US has 
proved to be a high sensitive and non-invasive tool in the study of enthesis. 
Furthermore, US elemental lesions included in enthesis pathology have been described 
(17, 18) and consensus about definitions initiated.  
 
The importance of enthesitis in SpA is growing, since the new ASAS 
classification criteria for peripheral SpA includes enthesitis as one of the three entry 
criteria (the other two being arthritis and dactylitis (19). It is also included in the 
EULAR recommendation for psoriatic arthritis management (20), which recommends 
anti-TNF therapy for patients with active enthesitis and/or dactylitis and insufficient 
response to non steroidal anti-inflammatory drugs or local steroid injections. One of the 
major problems in daily practice is the diagnosis and monitoring of enthesitis, which is 
consistent with the lack of sensitivity and reliability reported in the previous literature 
(21). It has been suggested that imaging techniques are superior to clinical examination 
for this purpose, and even US might be superior to MRI for detecting early signs of 
enthesopathy (22). The Outcome Measures in Rheumatology Clinical Trials 
(OMERACT) define enthesopathy as “abnormally hypoechoic (loss of normal fibrillar 
architecture) and/or thickened tendon or ligament at its bony attachment (may 
occasionally contain hyperechoic foci consistent with calcification), seen in 2 
perpendicular planes that may exhibit Doppler signal and/or bony changes including 
enthesophytes, erosions, or irregularity” (23). This definition includes the principal 
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lesions of the enthesis at bone and enthesis tendon insertion identified by 
ultrasonography, and it is now widely cited and accepted in the US community. On the 
other hand, there are multiple studies that added the bursa to the elementary entheseal 
lesions considered in the OMERACT enthesopathy definition (14-16, 24-26).  
 
We have previously developed and validated an enthesis US score index, the 
MASEI (Madrid Sonographic Enthesis Index) that includes de Achilles bursa, see 
figure 1 (24). 
 
 
Figure 1 Images on the left: ultrasonographic appearance of entheseal insertions, from the top: 
plantar aponeurosis insertion, calcaneal Achilles tendon insertion, distal patellar enthesis, proximal 
patellar enthesis, quadriceps tendon enthesis, triceps tendon enthesis. On the right side, The MASEI: 
ach item scores one point, except for calcification (0, 1, 2 or 3) and erosion and Doppler signal (0 or 
3). The total possible score on both sides (12 entheses) is 136. Sensitivity 83.3%, specificity 82.8%, 
positive predictive value 80.8%, negative predictive value 85.7%, positive likelihood ratio (LR+) 
4.87, negative likelihood ratio (LR-) 0.19 
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In fact, bursa was included in 46% of enthesis studies in a recently systematic 
literature review (17). This is in agreement with the concept of “synovio-entheseal 
complex”, which includes the link between enthesitis and osteitis in SpA. It has been 
clarified in recent studies that demonstrate not only a close functional integration of the 
enthesis with neighbouring bone, but also the connection between enthesitis and 
synovitis (12, 13, 27-29). Today, the debate is open and the relevance of bursa in 
previous publications remains sparse, likely because bursa seems to be a non-specific 
SpA entheseal lesion, and is often mistaken for sport and overuse pathology (30). 
Therefore, new insights about the understanding of the bursa in the pathogenic 
process in SpA could be relevant in the development of: a) US definitions, we have 
OMERACT enthesopathy definition but we are waiting for enthesitis definition, and b) 
US disease scores with diagnostic purpose or to assess disease activity or damage, and 
to monitor patients’ response to drugs. In this sense, knowledge of which entheseal US 
lesions are related to other SpA disease activity outcomes could be relevant.  
 
In this Thesis work we use two-dimensional (2D), in grey scale and Doppler, 
and three-dimensional (3D) US to assess the prevalence and relevance of the bursa-
synovial lesión in SpA, using as model the Achilles enthesis. We also determine the 
construct validity of enthesis US in the assessment of disease activity in SpA. 
 
1.2.2. Ultrasonography of the Sacroiliac Joints in Spondyloarthritis 
 
Sacroiliac joint (SIJ) involvement is a distinctive and characteristic feature of 
SpA. The diagnosis of AS relies on a combination of clinical symptoms with 
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unequivocal radiographic sacroiliitis (31). X-ray radiography reveals structural damage 
caused by inflammation but cannot detect active inflammatory lesions, and the 
diagnosis of AS is commonly delayed by an average of 6–9 years after the onset of 
symptoms (32, 33). Moreover, at 10 years from the first presentation of the disease, 25–
35% of patients still do not have radiographic sacroiliitis (3). Therefore, new imaging 
techniques are required for the early diagnosis and assessment of inflammatory activity 
in SpA. 
In the last decade, MRI has been increasingly used to visualize inflammation in 
the SIJs, and it has now been included in the new ASAS criteria for the classification of 
axial SpA (34). It has become clear in recent years that active inflammatory lesions are 
visible on MRI long before definite lesions on plain radiographs are detectable (8). 
Although MRI can shorten the interval between the onset of symptoms and the 
radiographic diagnosis of sacroiliitis, the availability of MRI is limited in many 
countries, and the technique is relatively time-consuming and cost-intensive.  
Enthesis ultrasound has demonstrated that it is useful for discriminating patients 
with long-standing SpA from those with early SpA (14, 24, 35, 36). However, even in a 
less explored field, such as inflammation in the SIJs, US can be used by applying 
different methods, including grayscale or colour Doppler ultrasound (CDUS), spectral 
Doppler resistive index (RI) and contrast-enhanced media (37-43).  
Thus far, there have been very few studies published assessing active 
inflammatory lesions in the SIJs using ultrasound.  
In this Thesis work we study the validity of CDUS, compared to physical 
examination as the gold standard, in the assessment of active inflammation of the SIJs 
in patients with SpA.  
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1.2.3. Ultrasonography of the Nail and the extensor tendon enthesis 
 
The importance of nail disease in subjects with psoriasis is being increasingly 
recognised (44). Clinically, nail disease is associated with pain, functional loss, 
disfigurement and psychological distress (45). From the rheumatological perspective, 
the presence of nail disease is a predictor for the development of PsA (46). In PsA 
patients, nail disease is associated with arthritis of the distal interphalangeal (DIP) joint 
(47, 48). The nail is directly anchored to the underlying bone by structures including the 
extensor tendon (49-51). Enthesopathy is a generalised feature of both psoriasis and 
PsA and we have recently demonstrated that in psoriasis patients, nail disease is 
associated with a greater degree of systemic enthesopathy (52) (see figure 2). 
                      
 
 
Presently, assessment of nail disease is difficult given the limited utility of 
clinical assessment tools for the nail, which include the nail psoriasis severity index 
Leeds Insti tute of Molecular Medicine
Nail 
plate
Extensor 
tendon 
(ET)
Distal 
Phalanx 
(DP)
Nail root 
(NR)
Sagittal section of DIPJ SL = Superficial laminaDL = Deep lamina
Extensor tendon enthesis
Tan, et al. Rheumatology 2007;46(2):253-6
Images courtesy of Michael Benjamin
Figure 2 This is the extensor tendon enthesis on histology. We see that the extensor tendon is not 
only attached to the dorsal aspect of the base of the distal phalanx, but also extended more distally as 
the superficial lamina of dense fibrous connective tissue to connect with the nail root. A further deep 
lamina forms a thick periosteum on the distal phalanx 
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(NAPSI) and the modified NAPSI (mNAPSI) (53, 54). Recently MRI, ultrasonography 
(US) and optical coherence tomography have been reported as possible tools for a more 
objective assessment of nail disease (55-58). US has wide availability in the 
rheumatology setting, modest costs, a high resolution and allows good visualisation of 
tendons and entheses. With respect to the nail matrix region, we were especially 
interested to determine whether US had the capability to detect local DIP joint 
enthesopathy in PsA and psoriasis patients. No USbased imaging study of the nail has 
considered the matrix region before.  
 
Therefore in this Thesis work we assess the utility of US for the assessment of 
psoriatic nail disease including both the nail plate and nail matrix region. 
 
1.3. OCT and US in the assessment of nail disease in Psoriasis and 
Psoriatic Arthritis 
 
Nail disease represents both a clinically and pathophysiologically important 
aspect of both psoriasis and PsA. In psoriasis, nail involvement may be associated with 
significant pain and functional impairment  (45). The pathogenesis of several matrix and 
plate lesions including pitting, leuconychia and onycholysis is still not clearly defined. 
The historical difficulties in assessing treatments for nail psoriasis have in part stemmed 
from the lack of objective assessment tools, as well as the duration of treatment needed 
to see a response. Currently these lesions may be clinically scored and evaluated using 
the Nail Psoriasis Severity Index (NAPSI) or the modified NAPSI (mNAPSI) system 
(53, 54).  
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The advent of biological therapies which effectively treat psoriasis, PsA and nail 
disease has further heightened the importance of understanding nail involvement. Nail 
disease scores are one of the outcome measures used to assess the success of therapy, 
and therefore it is important to have a measure which is objective and sensitive to 
change. From the rheumatological viewpoint, nail disease is important since it is a 
predictor of future PsA development (46). Nail disease is also more common in PsA 
compared to psoriasis without arthritis (59-62). The basis for this observation has now 
become more clear as entesitis (inflammation at tendon and ligament insertions) has 
been shown to be a key feature of the skeletal manifestations of PsA (63, 64). It has 
been suggested that the normal nail is anchored to the skeleton via a network of 
entheses (50). Patients with nail disease also have more subclinical enthesitis both at the 
distal interphalangeal joint level as well as at remote sites (52, 65), although the link 
between the different patterns of nail disease and subclinical entesitis remains enigmatic 
(66, 67). A combination of these dermatological and rheumatological issues has led to 
an increased interest in imaging of the nail to better understand disease mechanisms.  
 
Our group previously used both conventional and high-resolution MRI to image 
nail disease and to show that the nail is functionally integrated with the skeleton, as 
outlined above (68, 69). Whilst MRI is good for demonstrating the bone and soft tissues 
around the nail, the nail itself is very poorly visualised due to its low water content. 
Several studies have reported the use of US in nail evaluation. Given the accessibility 
and low cost of US, it may become the method of choice for nail disease evaluation (56, 
65, 70, 71). Nevertheless, there is a need for improved nail imaging techniques for 
making a diagnosis, understanding disease mechanisms and monitoring the response to 
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therapy.  
 
Recently our group reported on our preliminary experience with optical 
coherence tomography (OCT) for the assessment of nail disease in psoriasis (55). The 
accuracy of OCT for measuring nail thickness has previously been reported (57). OCT 
is a non-invasive optical imaging technique that has the advantage of incredibly high 
spatial resolution compared to other clinically available methods. It is already in 
dermatological use for the assessment of skin tumours (72-75).   
 
  
 
                                          
 
 
As the light-based analogue of US pulse-echo imaging, OCT systems focus a 
Figure 3 Image of an OCT machine (Michelson Diagnostics, Orpington, UK) 
 
Figure 4 Image of the OCT probe used (VivoSight Topical OCT probwe (multibeam frequency-
domain type OCT with a central wavelength of 1,305nm and a sweep range of 150nm 
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low-intensity infrared beam in tissue and analyse scattered light to provide tomograms 
and 3D volumes of morphology up to 2 mm below the surface. While ophthalmic OCT 
has been in use since the early 1990s, advanced laser technology and multibeam 
modalities have enabled the development of high-speed and ultra-highsensitivity 
‘frequency-domain OCT’ which provides the superior contrast necessary to create 
dermatological images with <10 μm resolution at video rate (76, 77).  
 
In this Thesis work we compare OCT and US of the nail to ascertain which of 
them is the best imaging modality and how they compare to clinical assessment. We 
also describe in detail the anatomical location of the different psoriasis-associated nail 
lesions. 
 
1.4. Predictive Factors in Spondyloartrhitis and Psoriatic Arthritis 
1.4.1. Association between enthesitis and nail disease in Psoriatic 
Arthritis 
 
Psoriasis affects approximately 2% of the population and up to 30% of these will 
develop PsA (78-81). As dermatologists usually see patients with psoriasis before 
arthritis develops they are well placed to diagnose PsA early. Now that effective 
therapies for the suppression of PsA exist, the early recognition of PsA has important 
consequences for optimal patient management. 
 
Currently, the conceptual basis for the link between psoriasis and nail disease 
and subsequent PsA is poorly understood. It has been suggested that enthesitis is the 
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primary lesion that underscores the diverse skeletal manifestations of PsA (82). It has 
also been demonstrated that subclinical enthesopathy and associated osteitis is present 
in up to 50% of patients with psoriasis with no arthritis (46, 83, 84). Another stream of 
research has shown that the presence of nail disease is a harbinger for the future 
development of PsA (46). These findings are noteworthy because it has been shown that 
psoriatic nail disease in PsA is intimately associated with enthesopathy of the distal 
interphalangeal joint and that the nail is functionally integrated with the enthesis (49, 
50, 69). 
 
During the past decade it has emerged that enthesitis and associated osteitis are 
the common denominators underlying the multifaceted skeletal manifestations of PsA 
that include axial and appendicular disease (63). In keeping with the importance of 
enthesitis as the key pathological lesion in PsA, some studies have shown enthesopathy 
in asymptomatic large insertions of the lower limbs in patients with SpA including PsA 
(15). This is reminiscent of studies in inflammatory oligoarthritis, in which US detected 
synovitis in joints that were clinically uninvolved (85). Of even greater importance is 
that several studies have shown subclinical enthesopathy or osteitis in up to 50% of 
psoriasis patients with no skeletal symptoms (84). 
 
These combined clinical and imaging observations suggest that there may be a 
link between systemic enthesopathy and psoriatic nail disease. Therefore, we posed the 
question as to whether nail disease in psoriasis is linked to a greater degree of systemic 
enthesopathy compared with psoriasis patients without nail disease in a previous study 
(52). In that study, we confirm that enthesopathy is common in psoriasis patients 
without clinical arthritis. Moreover, subclinical enthesopathy is especially associated 
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with nail involvement in a cross-sectional analysis. Those findings suggested that nail 
disease is in some way linked to the expression of enthesitis including subclinical 
disease. 
 
 
                
                                
 
 
 
Figure 7    Longitudinal US scan of the origin of the patellar tendon of the same patient showing 
severe thickening (White line 0.7mm), hypoechogenicity (*) and a large enthesophyte 
Figure 5  Comparison of median US scores related to inflammation and chronicity in psoriasis 
patients with and without nail disease and healthy controls: 
Figure 6    Photograph of a thumb nail of a patient with psoriasis, showing onycholysis and an oil 
drop spot 
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Ultrasonography is well suited to the assessment of entheses and is able to depict 
soft tissue thickening and oedema in addition to new bone formation and erosions (23). 
In recent years, power Doppler (PD) ultrasonography has been increasingly used in 
rheumatology as it identifies vascular abnormalities known to be associated with 
inflammation. PD ultrasound to some extent provides a reflection of the degree of 
angiogenesis, which is critically related to joint damage and therapeutic responses to 
drugs (86-88). An extra-articular PD signal has been demonstrated in both PsA and 
psoriasis patients (89-91). However, there is limited work directly comparing PD 
changes at the insertions between patients with PsA and psoriasis. Such a link would 
offer a novel unifying concept for nail disease, systemic enthesopathy and the future 
development of PsA. 
The purpose of this part of the Thesis work is to undertake ultrasonography of 
symptomatic and asymptomatic insertions in cases with PsA and cases with psoriasis, 
the latter having no clinical arthritis. The hypothesis tested was that the imaging 
phenotypes might differ between PsA patients and psoriasis cases without clinical 
arthritis. In particular, we hypothesised that the enthesopathy associated with PsA 
would have a greater degree of vascularisation compared to that seen in psoriasis 
without arthritis. We also postulated that subclinical vascular changes at the entheses 
might be associated with more widespread disease activity in PsA. Such an imaging 
biomarker could be helpful in understanding and predicting the disease evolution from 
psoriasis to PsA, which at the present time is not fully understood. 
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1.4.2. Predictors of outcome in Oligoarthritis and 
Spondyloarthritis 
Oligoarthritis is an inflammatory arthritis affecting ≤4 joints (92, 93). It 
represents either an early clinical presentation or a unique disease phenotype within the 
conditions collectively termed the seronegative spondyloarthropathies. Oligoarthritis 
typically affects young people causing high morbidity (94, 95) and it may have a 
variable outcome although long term follow up data are sparse (96-98).  
 
The majority of published studies have only reported on short/middle term 
outcomes. Some reports have described as many as 75% of patients with ReA having 
persistent disease at 6 months (96), whereas other cohort studies have suggested rates of 
persistence as low as 15%. In our first study, at 12 months of follow up, 51% of patients 
satisfied criteria for complete response (absence of synovitis) (92). In the second study, 
at 12 months, up to 81% of the patients in the early intervention group had no clinical 
evidence of synovitis compared with 57% of the patients in the conservative group (93). 
Both reports indicated a significant benefit from an early intervention protocol in the 
short term, with better results in the second study, suggesting that this may have been 
due to the early use of sulphasalazine (SSZ) as a DMARD. 
 
As part of the Thesis work, we aim to assess the long term follow up of these 
patients.  We were interested in particular, to assess the prognostic role of an early 
intervention.  
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2. HYPOTHESIS 
 
1. HLA–B27 status determines the severity of bone marrow oedema lesions in PsA 
patients with inflammatory back pain. A link between bone marrow oedema and HLA–
B27 in axial PsA would have implications both for an improved understanding of the 
disease process and for MRI interpretation in the clinical setting. 
2. The bursa-synovial of the Achilles enthesis is a relevance lesion in SpA and it US 
examination can be useful in the assessment of disease activity in early  SpA. 
3. CDUS can be a useful tool in the assessment of active inflammation of the SIJs in 
patients with SpA. 
4. Nail involvement is specifically linked to extensor tendon enthesopathy. 
5. The US imaging phenotypes might differ between PsA patients and psoriasis cases 
without clinical arthritis. In particular, we hypothesise that the enthesopathy associated 
with PsA will have a greater degree of vascularisation compared to that seen in psoriasis 
without arthritis. We also postulate that subclinical vascular changes at the entheses 
might be associated with more widespread disease activity in PsA. Such an imaging 
biomarker could be helpful in understanding and predicting the disease evolution from 
psoriasis to PsA, which at the present time is not fully understood. 
6. An early treatment intervention in an Early Oligoartrhitis Cohort should lead to a 
better long term prognosis.  
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3. OBJECTIVES 
 
The main objectives of this Thesis work are: 
1. To determine the prevalence, on MRI, of bone marrow oedema lesions in 
symptomatic axial PsA, and to compare this prevalence with that in 
nonradiographic axial SpA and ankylosing spondylitis (AS) and its relationship 
to HLA–B27 status. 
2. To assess the prevalence and relevance of the bursa-synovial lesion in SpA and 
to evaluate the construct validity of enthesis US in the assessment of disease 
activity in early SpA. 
3. To assess the validity of CDUS in SIJ in SpA. 
4. To investigate the nail plate, nail matrix and adjacent tendons in subjects with 
psoriatic nail disease with ultrasonography and to compare those findings with 
OCT images. 
5. To test the hypothesis that subclinical enthesopathy in PsA was associated with 
an ‘inflammatory’ or vascular phenotype compared to that seen in psoriasis 
using ultrasonography with power Doppler (PD). 
6. To report the long-term outcome in the Leeds Early Oligoarthritis Cohort and 
to assess the prognostic role of an early treatment intervention in these patients.  
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4. OVERVIEW 
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5. PUBLICATIONS 
 
5.1. MRI in the assessment of axial Psoriatic Arthritis and 
Spondyloarthritis 
 
5.1.1. ARTICLE 1  
 
TITLE: “Magnetic Resonance imaging assessment of axial psoriatic arthritis: extent of 
disease relates to HLA-B27” 
JOURNAL: Arthritis and Reumatism, 2013 Sep; 65(9): 2274-8 
AUTHORS: Castillo-Gallego C, Aydin SZ, Emery P, McGonagle, Marzo-Ortega H.  
 
The aim of this study was to determine the prevalence, on MRI, of bone marrow 
oedema lesions in symptomatic axial PsA, and to compare this prevalence with that in 
non-radiographic axial SpA and AS and its relationship to HLA–B27 status. 
5.1.1.1. PATIENTS AND METHODS 
5.1.1.1.1. MRI scan selection procedure  
The study was a cross-sectional audit of MRI scans of the lumbar spine (L-
spine) and SI joints performed consecutively between May 2007 and February 2011 in 
the Rheumatology department of a large teaching hospital, to reflect service 
development. MRI scans were requested for diagnostic purposes in symptomatic 
patients with inflammatory back pain and a background clinical suspicion or diagnosis 
of PsA, non-radiographic axial SpA, or AS. Eligible scans were retrieved from the 
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hospital intranet computer system for scoring. The audit had the approval of the local 
governance committee. 
 
5.1.1.1.2. Patient groups   
The clinical diagnosis according to the requesting clinician, HLA–B27 status, 
and demographic data were retrieved from the clinical notes. Subjects were categorized 
into 3 groups: patients with PsA (patients meeting the Classification of Psoriatic 
Arthritis Study Group criteria), patients with nonradiographic axial SpA (patients 
fulfilling the ASAS criteria for axial SpA but not the modified New York criteria for 
AS), and patients with AS (patients fulfilling the modified New York criteria for AS).  
 
5.1.1.1.3 MRI scoring 
 MRI scans were scored independently by 2 expert readers (HMO and DGM) 
who were blinded to the clinical characteristics of the patients. The readers used the 
semiquantitative Leeds Scoring System for bone marrow oedema lesions representative 
of inflammation in the spine and SI joints. This scoring system allows for estimation of 
the severity of a lesion by combining the concepts of extent and intensity in one 
definition with lesions ranked on a scale of 0–3 as described by the Leeds MRI Scoring 
Index. A lesion graded as severe (grade 2) is considered clinically significant. For 
analysis, concordant data from the 2 readers were used to report on definite lesions. An 
overall score for inflammatory activity was calculated as the sum of bone marrow 
oedema scores. 
 
5.1.1.1.4 Statistical analysis 
Data are expressed either as frequencies or as the median and range. The total 
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MRI scores of the 3 different groups of patients and patients with or without HLA–B27 
were compared using the Mann-Whitney U test. The prevalences of severe MRI lesions 
(grade 2) were compared using the chi-square test. Statistical analysis was performed 
using SPSS software, version 11.5. 
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5.2.  US in Spondyloarthritis and Psoriatic arthritis 
 
5.2.1. ARTICLE 2:  
 
TITLE: “Achilles enthesis ultrasound: the importance of the bursa in spondyloarthritis” 
JOURNAL: Clinical Experimental Rheuamtology, 2013 May-Jun; 31(3): 422-7 
AUTHORS: Falcao S, de Miguel E, Castillo-Gallego C, Peiteado D, Branco J, Martin 
Mola E.  
 
5.2.1.1 PATIENTS AND METHODS 
5.2.1.1.1. Patients group 
This part of the Thesis work is a blind and controlled Achilles enthesis bursitis 
US study performed on early-stage SpA patients. The patient sample was selected 
consecutively from individuals attending the Early Spondyloarthritis Unit (forty-six 
patients), as part of the ESPERANZA programme. The referral criteria included: 1) age 
below 45, 2) symptoms duration between 3 and 24 months, and 3) at least one of the 
following: a) inflammatory low back pain, defined as at least two among insidious 
onset, morning stiffness for more than 30 minutes, or clear improvement of the 
symptoms with physical activity, but not relieved by rest, b) asymmetric arthritis, 
preferably of the lower limbs, or c) low back pain or arthralgia and at least one among 
psoriasis, inflammatory bowel disease, anterior uveitis, family history of spondylitis, 
psoriasis, radiographic sacroiliitis or HLA-B27+ status. Patients were classified as SpA 
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according to accepted classification criteria. All patients completed the Spanish version 
of Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Bath 
Ankylosing Spondylitis Functional Index (BASFI); Bath Ankylosing Spondylitis 
Radiology Index (BASRI) and peripheral joint count were also registered on the same 
day of the visit. 
 
5.2.1.1.2. Controls group 
  Forty-six sex-matched controls (92 Achilles enthesis) were included.  
 
5.2.1.1.3. Ultrasound scanning protocol 
  Ultrasonography was performed by an experienced rheumatologist, who was 
blinded to patients’ clinical or therapeutic data; and subjects were advised to withhold 
these data with the US examiner. The patients were asked to take a prone position with 
the feet hanging out the examination table in neutral position for examination of the 
Achilles tendon. In all cases, bilateral examination was carried out after having 
previously applied gel to the skin to provide an acoustic interface; particular attention 
was paid on not applying probe pressure on the anatomical structures under 
examination. The same protocol was used for both 2D and 3D examinations.  
 
5.2.1.1.4. 2D US and 3D US examination 
 During the same scanning session, US was firstly performed in B-mode 
modality using a longitudinal and transverse scanning technique to detect 
morphological changes and immediately afterwards by using Doppler technique to 
access abnormal vascularisation. Immediately after the 2D US exploration, the 
acquisition of 3D data sets was obtained placing the volumetric probe over the area of 
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interest. All acquired images were stored in digital format. Methods of US image 
interpretation. Presence of retrocalcaneal bursa was defined by a grey-scale US aiming 
at detecting bursal enlargement. The maximal diameter obtained on longitudinal and 
transversal scan was collected. The measurement end of bursa was classified in a 
dichotomous scale (presence/absence) and a continuous quantitative scale. The presence 
or absence of Doppler signal in the cortical bone profile or bursal area was also 
recorded. To improve reliability and accuracy a quantitative measurement was 
determined in the storage 3D volumes of 53 consecutive SpA patients and 23 healthy 
controls, the average of three consecutive measurements of the maximal thickness 
obtained in longitudinal and transverse axes was scored. 
 
5.2.1.1.5. Statistical analysis 
 Mean ± standard deviation was used to describe the demographic characteristics 
of patients and US features. To compare quantitative and qualitative variables of 
clinical, biochemical and US data, the independent sample t -test and the chi-square test 
were used, respectively. The reliability analysis was performed using the kappa 
correlation coefficient for qualitative presence of bursa, and intraclass-correlation 
coefficient (ICC) for bursa thickness measurement. ROC curves were used to calculate 
sensitivity and specificity in the different cut-off points. p -values of less than 0.05 were 
considered to be statistically significant. All data analyses were performed with SPSS 
version 11.5 software (SPSS, Chicago, IL, USA). 
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5.2.2. ARTICLE 3 
 
TITLE: “Can we use enthesis ultrasound as an outcome measure of disease activity in 
spondyloarthritis?: A study at the Achilles level” 
JOURNAL: Rheumatology 2015 oct; 54: 1557-1562 
AUTHORS: Falcao S, Castillo-Gallego C, Peiteando D, Branco J, Martin Mola E, de 
Miguel E.  
 
5.2.2.1. PATIENTS AND METHODS: 
In this part of the Thesis work we performed a longitudinal enthesis US study in 
patients with early SpA. Approval was obtained from the ethics committee of the 
Hospital Universitario La Paz. All patients signed an informed consent form. 
 
5.2.2.1.1. Patients 
The sample included the baseline visit for 146 consecutive patients attending the 
Early SpA Unit as part of the ESPERANZA programme. The patients were diagnosed 
with SpA according to accepted ASAS classification criteria. All patients completed the 
Spanish version of the BASDAI and the BASFI. Peripheral joint count and the presence 
of heel pain were also registered on the same visit day. Laboratory tests included ESR, 
CRP and HLA-B27. The CRP version of the Ankylosing Spondylitis Disease Activity 
Score (ASDAS) and the BASRI were calculated. 
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5.2.2.1.2. US examination 
Patients underwent an Achilles US examination at baseline, and 6 and 12 
months according to the Madrid Sonographic Enthesitis Index (MASEI) (24). In this 
study, the only score was for the Achilles enthesis. The US was performed by one 
rheumatologist trained in enthesis US using a Logiq 9 machine (General Electric, 
Wauwatosa, WI, USA) with a linear probe at 9-14 MHz. The US examiner was blinded 
to the status of the subject. The elemental lesions were defined according to 
OMERACT definitions and the original MASEI publication. To improve precision, 
erosion was defined as cortical breakages with step-downs of more than 1mm in depth 
and width in both the longitudinal and transverse axes. Previous studies by our group 
have shown good to excellent reliability results for the MASEI score with an intraclass 
correlation coefficient range of 0.77 (95% CI 0.20, 0.95; P<0.01) to 0.97 (95% CI 0.90, 
0.99; P<0.0001). 
 
5.2.2.1.3. Statistical analysis 
The mean (S.D.) was used to describe the demographic characteristics of 
patients and US features. To compare quantitative and qualitative variables of clinical, 
biochemical and US data, an independent sample t test and chi-squared test were used, 
respectively. Pearson correlation coefficients were calculated to assess the relationships 
between disease activity measures and US features. P-values of<0.05 were considered 
statistically significant. All data analyses were performed with SPSS version 17.0 
software (IBM, Armonk, NY, USA). 
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5.2.3. ARTICLE 4 
 
TITLE: “Colour Doppler and spectral  Doppler ultrasound detection of active 
sacroileitis in spondyloarthritis compared with physical examination” 
JOURNAL: Rheumatology International (submitted, under revision) 
AUTHORS: Castillo-Gallego C, De Miguel E, García-Arias M, Plasencia Ch, Lojo-
Oliveira L, Martín-Mola E. 
 
5.2.3.1. PATIENTS AND METHODS: 
5.2.3.1.1. Patients 
This part of the Thesis work was a cross-sectional, blinded and controlled study 
of the SIJs, in which three populations were compared. We studied 108 patients, who 
were divided into three groups: a) 53 patients diagnosed with SpA who had IBP; b) 28 
patients diagnosed with SpA who did not have IBP or SIJ tenderness but had normal 
physical examinations of the SIJs; and c) a group of 27 subjects, including 19 healthy 
controls and 8 subjects, with mechanical lumbar pain. All of the patients included who 
were diagnosed with SpA met the ASAS classification criteria for axial SpA. 
Inflammatory back pain (IBP) was defined as pain in the lumbosacral according to 
ASAS criteria, assessed by a rheumatologist.  
The study was conducted according to local regulations and the Declaration of 
Helsinki, and the ethical committee of our hospital granted approval for the study.  
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5.2.3.1.2. Physical examination 
A rheumatologist, who previously had performed the clinical history, assessed 
the patients. The physical examinations of the SIJs included the following: sacral sulcus 
tenderness, iliac compression, the midline sacral thrust test, Gaenslen’s and Patrick’s 
tests. The results of these tests were reported as positive if any of these manoeuvres 
provoked pain in the right or left SIJ or as negative if none of them provoked pain. Both 
right and left SIJs were assessed and scored independently in each patient.  
 
5.2.3.1.4. CDUS 
CDUS examination of the SIJs was performed using a Logiq 9 equipment 
(General Electrics Medical Systems, Milwaukee, Wisconsin, USA) fitted with a 9-14 
MHz lineal probe. The ultrasonographer was blinded to the clinical data of the patient. 
The color Doppler settings were the same for all of the participants, with a gain setting 
just below the noise level and 5 MHz of Doppler frequency. The cases and the controls 
were examined in the prone position. The probe, in the transverse position, was moved 
from the cephalic origin of the SIJ to the end of the SIJ, caudal to the second sacral 
foramen (figure 8). Vascularization within the SIJs was explored by the presence of a 
CDUS signal. The sacral foramen, with its vessels, was always identified, but a Doppler 
signal in this area was not considered to be a Doppler signal in the SIJs (figure 9).  
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Figure 8     Movement of the US probe, in transverse position, from the cephalic origin of the SIJ to 
the end of the SIJ, caudal to the second sacral foramen. end of sacroiliac joint.  
 
Figure  9     Images of SIJ US, the left one only grey scale and the right one with colour Doppler  
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Figure 10   Image of CDUS of the left SI joints: no Doppler signal detected 
Figure 11   Image of CDUS of the left SI joints: Doppler signal detected 
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5.2.3.1.5. Spectral Doppler 
If any Doppler signals were detected within the SIJs, the RI was measured. The 
US flow patterns in the SIJs with activity on CDUS were evaluated using quantitative 
spectral Doppler with automatic calculation of the RI (RI = [peak systolic flow - end 
diastolic flow/peak systolic flow]). The values of the RI ranged between 0 and 1. 
Measurements in each examination area were repeated at least twice, and the mean 
values of those measurements were used as the results. If there was no Doppler signal 
within the SIJs, the RI was calculated from the subcutaneous vessels above the SIJ. 
Doppler of each SIJ was classified, after calculation of the cut-off point with ROC 
curves (see results), as positive when both CDUS and RI were < 0.75 within the SIJ 
area. 
 
 
 
 
Figure 12  Image of CDUS and Spectral Doppler of the Right sacroiliac joint with a Doppler signal 
and spectral Doppler with a resistive index of 0.55 
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5.4.1.5. Statistical analysis 
Means ± standard deviations were used to describe the demographic 
characteristics. A statistical analysis was performed, estimating the sensitivity and 
specificity against the gold standard, and ROC curves were constructed to calculate the 
sensitivity, specificity, accuracy and best cut-off point of the spectral Doppler RI to 
distinguish physiological from pathologic SIJ flow. A chi-square test for the comparison 
of categorical variables and paired and unpaired t tests for continuous variables were 
applied.  
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5.2.4. ARTICLE 5 
 
TITLE: “Ultrasonographic Assessment of nail in Psoriatic Disease Shows a Link 
Between Onychopathy and Distal Interphalangeal Joint Extensor Tendon Enthesopathy” 
JOURNAL: Dermatology 2012 nov; 225: 231-235 
AUTHORS: Aydin SZ, Castillo-Gallego C, Ash ZR, Marzo-Ortega H, Wakefield RJ, 
Wittmann M, McGonagle D.  
 
5.2.4.1. PATIENTS AND METHODS 
5.2.4.1.1. Patient groups and clinical assessment 
This part of the Thesis work was approved by the Leeds (East) Research Ethics 
Committee. Informed consent was obtained from all participants. A total of 86 psoriasis 
patients with or without PsA (169 nails) and 20 healthy controls (HC) (40 nails) were 
assessed for the purpose of this study. Macroscopic nail features were assessed by 
clinical examination. Abnormalities including onycholysis, pits, nail plate crumbling, 
leuconychia, splinter haemorrhages, nail bed hyperkeratosis and red spots in the lunula 
were recorded and scored by using the mNAPSI scoring system by a rheumatologist 
experienced in this assessment. This assessor was blinded to the US findings.  
 
5.2.4.1.2. Ultrasonography 
An US scan of patients’ nails was performed by a rheumatologist fully trained in 
musculoskeletal US (S.Z.A.), using a Logiq E9 machine (General Electric, Wauwatosa, 
Wisc., USA) and a linear probe at 18–10 MHz. Two nails per patient were scanned by 
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US. The clinician performing the mNAPSI selected the most severely involved nail and 
the corresponding nail on the other hand (irrespective of involvement) to be scanned. 
The ultrasonographer was unaware of the presence or absence of nail disease and was 
only informed which finger was to be scanned. The nail plate and nail matrix were 
scanned in every patient. A thick gel layer allowed for appropriate transmission of 
ultrasound without any additional device. All US assessments were performed using a 
multiplanar technique, scanning the nail from medial to lateral sites and from the lunula 
to the distal nail in order to provide as complete coverage as possible. Particular 
attention was paid to blind the sonographer from the clinical findings; the room was 
completely darkened during the US assessment and the patients and controls were asked 
not to talk to the sonographer prior to or during the US assessment. The sonographer did 
not perform a physical examination, therefore sites other than those involved in the US 
scan were not seen by the sonographer. The light of the US machine alone is not enough 
for the sonographer to see the nails clearly. Nail Plate Region. A dorsal longitudinal 
scan of the distal phalanx at the midline was used for thickness measurements. The 
thickness of the nail was measured as the maximum distance between the dorsal and 
ventral nail plates. The sonographic trilaminar appearance of the nail plate was 
evaluated. The trilaminar structure (two hyperechogenic bands with a hypo/anechogenic 
band in the middle) was documented as either present or absent.  
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Figure 13     US images of the nail.  Longitudinal (a) and transverse (b) scan of the healthy nail 
demonstrating the trilaminar structure as two hyperechoic lines (arrows) surrounding an anechoic line. 
(NP= nail plate; S= skin; DP= distal phalanx) 
Figure 14     US image of the nail.  Loss of the trilaminar appearance at the ventral plate seen as the 
irregularity and absence of the deeper hyperechoic line (arrow) (NP= nail plate; S= skin; DP= distal 
phalanx) 
 
Figure 15     US image of the nail.  Pitting and irregularity of the nail plate (arrows). (NP= nail plate; 
S= skin; DP= distal phalanx; DIPJ= DIP joint) 
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Figure 16     US image of the nail. Measurements of the thickness:  
a: nail thickness; the maximum distance between the ventral nail plate and the cortex of the distal 
phalanx at the level of the matrix. 
b: nail matrix thickness; the distance between the ventral nail plate and the cortex of the distal 
phalanx at the level of the matrix. 
c: skin thickness; the maximum thickness of the hyperechoic epidermis and hypoechoic dermis 
around the level of the DIPJ. 
  (NP= nail plate; S= skin; DP= distal phalanx; DIPJ= DIP joint) 
Figure 17     US images of the nail. An example of different enthesal and skin thickness (blue line) in 
a healthy control (a) and in a patient with psoriasis (b).  
The thickening of the extensor tendón (red line) and enthesis is seen in addition to hypoechogenicity 
(*) and an enthesophyte (E) (b) as well as the increased thickness of the skin. 
(DIPJ= DIP joint; DP= distal phalanx; MP: middle phalanx) 
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Pits and irregularities of the nail plate surface were noted as regions where the 
normal convexity of the nail plate was lost. Nail Matrix Region. The skin thickness was 
measured as the maximum thickness of the hyperechoic epidermis and hypoechoic 
dermis around the level of the DIP joint. The thickness of the matrix was measured as 
the distance between the ventral nail plate and the cortex of the distal phalanx at the 
level of the matrix, determined by a line perpendicular to the bone profile. With respect 
to the nail matrix region, the thickness of the extensor tendon at the level of insertion 
was assessed as normal or thickened by comparing it to the proximal part of the tendon. 
The grey-scale settings used for nail assessment were: frequency at 14 MHz, gain at 18 
dB and a dynamic range at 36 dB. 
  
5.2.4.1.4. Statistics 
Data are expressed either as frequencies or medians (range). The concordance 
between US and physical examination was evaluated using absolute agreements and 
kappa analysis and the prevalence of findings was compared using the x 2 test. The 
measurements of the HC and patients were compared using the Mann-Whitney U test. 
To test the differences between subgroups for the presence or absence of nail disease, 
the Kruskal-Wallis test was applied followed by the Mann-Whitney U test. To assess 
reproducibility, the images of randomly chosen 100 extensor tendons were reassessed 
for the presence or absence of thickening by the same investigator blinded to the nail 
plate findings, and this revealed a moderate agreement with a kappa value of 0.58. 
Statistical analysis was performed using SPSS version 11.5. 
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5.3. OCT and US in the assessment of nail disease in Psoriasis and 
Psoriatic Arthritis  
 
5.3.1. ARTICLE 6 
 
TITLE: “Potential use of optical coherence tomography and high-frecuency ultrasound 
for the assessment of nail disease in psoriasis and psoriatic arthritis” 
JOURNAL: Dermatology 2013 Aug; 227: 45-51 
AUTHORS: Aydin SZ, Castillo-Gallego C, Ash ZR, Abignano G, Marzo-Ortega H, 
Wittmann M, Del Galdo F, McGonagle D.  
 
5.3.1.1. PATIENTS AND METHODS 
5.3.1.1.1. Patient Groups and Clinical Assessment 
This part of the Thesis work was a ‘real-life’ evaluation of imaging performed 
within the clinics of the Leeds Teaching Hospitals. A total of 300 finger nails of 18 
patients with at least one diseased nail (5 psoriasis, 13 PsA) and 12 healthy controls 
(HCs) were assessed. All patients were aged >18 years. Macroscopic nail features 
including onycholysis, pitting, nail plate crumbling, leuconychia, splinter 
haemorrhages, nail bed hyperkeratosis and red spots in the lunula were scored using the 
mNAPSI scoring system by a rheumatologist who was blinded to the US and OCT 
findings. 
 
5.3.1.1.2. Ultrasound 
An US scan of finger nails was performed in patients with psoriasis by a 
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rheumatologist fully trained in musculoskeletal US (C.C.G.), using a Logiq E9 machine 
(General Electric, Wauwatosa, Wisc., USA) and a linear probe at 9–14 MHz. The US 
assessment was performed in a darkened room and the sonographer was blinded as far 
as possible to the presence or absence of arthritis and nail disease. Patients were asked 
not to communicate with the sonographer. All US assessments were performed using a 
multiplanar technique, scanning the nail from the medial to the lateral side and from the 
lunula to the distal nail in order to provide as complete coverage as possible. The nail 
plate, nail matrix and nail bed of all fingers of the hands were scanned. A thick gel layer 
allowed for appropriate transmission of US without any additional device. 
The nail plate is seen in normal nails as two hyperechogenic bands with a 
hypoechogenic band in the middle, which is thus called a trilaminar appearance. The 
loss of this trilaminar appearance of the nail plate and the presence of pits or 
irregularities in the nail surface were noted using grey-scale US. 
 
5.3.1.1.3. OCT Assessment 
All patients and controls were scanned using OCT by a different investigator 
(S.Z.A.) blinded to the clinical details using a VivoSight optical OCT Probe (Michelson 
Diagnostics, Orpington, UK) which is a multibeam frequency-domain type OCT with a 
central laser wavelength of 1,305 nm and a sweep range of 150 nm. The nail plates were 
assessed longitudinally from the lunula to the distal nail and from the lateral to the 
medial side. The OCT probe was applied directly to the nail without intermediate gel. 
The scanning of each nail lasted less than 1 min and did not cause dis- comfort to the 
subjects studied. OCT provided images of the nail plate, the nail bed and the matrix up 
to a depth of 2 mm and a width of 4 mm. The multislice mode was used, recording 100 
slices per nail with interslice spacing of 4 μm to provide densely sampled 3D ‘bread 
 92
 
slice’ image volumes. In standard OCT the nail plate appeared as a layered structure 
containing a number of horizontal homogeneous bands of varying intensity and 
thickness. At the lunula and at sites of leuconychia, distinct horizontal white bands were 
seen at the deep end of the nail plate and within the nail plate, respectively. We assessed 
these lesions as well as other findings within the nail plate and surface abnormalities 
that have not been described previously. 
 
5.3.1.1.4. Nail OCT images 
 
 
 
 
Normal nail 
Leukonychia 
 Intra-nail plate disordered 
 keratinisation 
Tip center matrix 
Pathological nails 
pits 
pits Intra-nail plate 
disordered keratinisation 
Subungueal  
haemorrhage 
Figure 18     Nail OCT images (normal and pathological nails) 
OCT showed remarkably high quality images of the nail, the adjacent nail matrix and the subungual 
epidermis and vessels.  
The most striking finding was that of leuconychia, manifesting as diffuse “white” lines running obliquely 
along the middle third of the nail.   
Pits were very superficial and were associated with disorders of the nail matrix keratinisation. 
OCT also showed other nail lesions as intra-nail plate disordered queratinisation and subungueal 
haemorrhage. 
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Figure 19     Nail OCT and corresponding US images 
OCT of the nails in psoriasis and PsA. Pitting is seen as an irregularity of the superficial nail plate, 
sometimes associated with an underlying shadow. a Focal pitting. b A more diffuse lesion seen as waving 
of the superficial nail plate. c Corresponding US image of the nail seen in a . NP = Nail plate. 
 
Figure 20     Appearance of hyperreflective lesions on OCT and the corresponding US images: 
a–c Appearance of hyperref lective lesions on OCT.  
a Linear regular stripes (seen clinically as leuconychia) located in between the two borders of the nail 
plate. b Thickening and irregularity of the superficial layer. c Hyperref lective spots, sometimes with an 
underlying shadow, depending on the density of the calcification.  
 
d, e Corresponding US images. 
d US image corresponding to a, demonstrating the well-depicted trilaminar appearance [nail plates seen 
as two white (hyperechoic) lines with a black line (anechoic) in between. e US image corresponding to c, 
with local losses of trilaminar appearance, but no focal lesions are seen in between the nail plates. 
Asterisks indicate loss of the trilaminar appearance. 
 
 94
 
5.3.1.1.5. Statistics 
Data are expressed either as frequencies or means (± standard deviation). The 
concordance between OCT, US and physical examination was evaluated using absolute 
agreements and kappa analysis and the prevalence of findings was compared by χ 2 test. 
The sensitivities, specificities and likelihood ratios of different OCT findings to 
differentiate psoriasis were calculated. Statistical analysis was performed using SPSS 
version 11.5. 
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5.4. Predictive factors in Psoriatic Arthritis and Spondyloarthritis  
 
5.4.1. ARTICLE 7 
 
TITLE: “The link between enthesitis and arthritis in psoriatic: a switch to a vascular 
phenotype at insertions may play a role in arthritis development” 
JOURNAL: Annals of Rheumatic Diseases 2013 Jun; 72(6): 992-5 
AUTHORS: Aydin SZ, As ZR, Castillo-Gallego C, Kwok C, Wilson C, Goodfield M, 
Gisondi P, Tan AL, Marzo-Ortega H, Emery P, Wakefield RJ, McGonagle DG. 
 
5.4.1.1. PATIENTS AND METHODS 
This part of the Thesis work was carried out at two European centres, at the 
Leeds Teaching Hospitals (UK) and the University Hospital Department of Verona 
(Italy). Ethics approval for the study was obtained at both sites. 
 
5.4.1.1.1. Patient groups and clinical assessment 
One hundred consecutive patients (42 with psoriasis and 58 with PsA) and 23 
HC were recruited. PsA patients were included if they fulfilled the CASPAR criteria.14 
Psoriasis patients were excluded if they had a current or previous history of arthralgia, 
arthritis or enthesitis. The clinical assessment was performed by one rheumatologist at 
each centre, who was blinded to the US data. This assessment included the psoriasis 
area and severity index (PASI), tender and swollen joint counts (TJC, SJC) and the 
Leeds and SPARCC enthesitis indices in the patients with PsA. Patients receiving 
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glucocorticoids and anti-tumour necrosis factor therapies were excluded from the study, 
those receiving disease-modifying antirheumatic drug therapy were recruited if they had 
active skin or joint disease (inad- equate responders). 
 
5.4.1.1.2. Ultrasonography 
US was performed by three rheumatologists fully trained in musculoskeletal 
ultrasound and with a special interest in scanning enthesitis (SZA and CCG in UK, IT in 
Italy). US was performed using a Logiq E9 machine (General Electric, Wauwatosa, 
Wisconsin, USA) in the UK and a Logiq 5 machine (General Electric) in Italy, both 
with a linear probe at 6–15 MHz. The lower limb entheses that have previously been 
described in the GUESS scoring system (including Achilles, plantar fascia, quadriceps, 
patellar tendon origins and insertions) were scanned. To enable blinding, patients were 
asked not to com- municate with the sonographer about their disease during the US 
assessment. The sonographer did not perform a physical examination, therefore sites 
other than those involved in the US scan were not seen by the sonographer. The room 
was completely darkened starting from the beginning of the US assessment. The light 
from the US machine alone is not enough for the sonographer to see the skin clearly. 
The patients were placed in a supine position to assess the entheses around the knee. 
The knee was extended to assess the presence of Doppler signal and semiflexed to 30° 
to assess the grey-scale (GS) changes. They were then asked to take a prone position 
with the feet over the end of the examination Table in a neutral position for visualisation 
of the entheses around the heel. The PD settings were standardised with a pulse 
repetition frequency of 800 Hz, a colour-mode frequency of 9.1 MHz and low wall 
filters. The colour gain was increased to the maximum level not generating PD signals 
under the bony cortex. All US assessments were performed using a multiplanar 
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scanning technique. 
 
5.4.1.1.3. Ultrasound images interpretation 
The GUESS scoring system was modified and the outcome measures in 
rheumatology clinical trials definition of enthesopathy was used to interpret ultrasound 
images: ‘abnormally hypoechoic (loss of normal fibrillar architecture) and/or thickened 
tendon or ligament at its bony attachment (may occasionally contain hyperechoic foci 
consistent with calcification), seen in two perpendicular planes that may exhibit 
Doppler signal and/or bony changes including enthesophytes, erosions, or 
irregularity’(5). Bursal enlargement was also scored. The thickness of the enthesis was 
measured at the level of insertions and was evaluated on a quantitative basis. Normal 
values for each insertion were accepted as reported in the literature (2) and less than 1 
mm of increase exceeding the threshold was scored as grade 1, 1 mm or greater but less 
than 2 mm of increase was scored as grade 2 and 2 mm or greater was scored as grade 
3. Erosions were also scored quantitatively by the máximum diameter of the erosion 
(grade 1, >0 mm but <2 mm; grade 2, 2 mm and <3 mm; grade 3, 3 mm). The rest of 
the assessments were scored on a semiquantitative basis (mild changes grade 1, 
moderate grade 2 and severe grade 3).  
 
It is now recognised that the enthesis represents an integrated organ comprising 
the insertion (which is avascular in health) and adjacent tendon, fibrocartilages and the 
immediately adjacent synovium when present.15 For the PD assessment we therefore 
looked for PD signal in all the components of the enthesis organ, including signals at 
the insertion and inside the adjacent bursa, wherever these were present. It is not 
possible to define the margins of the enthesis by US; however, the entheseal vascularity 
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was assessed when the Doppler signal was close to the cortical bone.  
 
US findings were categorised according to the following: GS changes related to 
inflammation (entheseal hypoechogenicity, thickening and bursal enlargement) were 
added up to calculate a ‘GS inflammation score’. PD scores were added up to calculate 
a ‘Doppler inflammation score’. These two scores created a ‘total inflammation score’. 
The GS changes related to chronic findings (calcifications, erosions and enthesophytes) 
were added up to calculate a ‘chronicity score’. These scores were summated to give a 
total US enthesopathy score. 
 
 
 
 
 
 
Figure 21     US findings on enthesis in psoriatic arthritis: The origin of patellar tendon with moderate 
thickening (white line); hypoecogenicity (*); small enthesophyte (e); calcifications (c) 
Figure 22     US findings on enthesis in psoriasis: hypoecogenicity (*); small enthesophyte (e) 
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5.4.1.1.4. Statistics 
Data are expressed either as frequencies, means (SD) or medians (range) 
according to the variability. The prevalence of each individual lesion by ultrasound in 
patients with or without arthritis was compared by using a 2 test. The Mann–Whitney 
U test was used to compare ultrasound scores between groups. Correlations between 
clinical parameters (TJC, SJC, PASI and disease duration) and ultrasound scores 
(separately for ultrasound scores related to inflammation, damage and total) were 
analysed using the Pearson correlation test.  
Statistical analysis was performed using SPSS V.11.5. To provide agreement 
between sonographers, all investigators agreed on definitions and the scoring system 
before the study both on saved images and while acquiring sample images. Stored 
images from the first 21 patients included in the study (total 1020 images) were scored 
by all three sonographers for GS and PD for all entheses. Intraclass correlation 
coefficient values were calculated for each pair of investigators and for all types of 
ultrasound scores used for the purpose of this study. 
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5.4.2. ARTICLE 8 
 
TITLE: “Long Term follow up of an early Oligoarthritis cohort shows that early 
aggressive intervention leads to drug free remission after 10 years: results from the 
LoTO study” 
JOURNAL: Accepted in International Journal of Clinical Rheumatology (14th 
March2017) 
AUTHORS: Castillo-Gallego C, Green MJ, Aydin SZ, Nizam S, Emery P, Marzo-
Ortega H. 
 
 
5.4.2.1. PATIENTS AND METHODS 
This part of the Thesis work is a single-centre, single time-point observational study 
of long term follow up of patients presenting with an early oligoarthritis (disease 
duration <12 months) from two historical cohorts of the Leeds Early Arthritis Clinic 
EAC. In the first study, subjects were treated with a protocol of intra-articular steroid 
injections into all clinically involved joints. In the second, subjects were randomized 
into an early intervention group with intra-articular steroid injections into all synovitic 
followed by DMARDs therapy with sulfasalazine or initial treatment with NSAIDs 
followed by intensive treatment on the second group.  
 
For the present report, subjects were identified through clinical records and were 
invited through letter to either attend for a single study visit or a telephone consult. 
Patients who did not respond to this first invitation were then contacted by telephone 
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and invited to answer a short questionnaire. Data collected included demographic 
variables. Investigations such as CRP or radiography (sacro-iliac joints/lumbar spine or 
any relevant joints) were only performed in attenders in case of clinical need or to 
clarify the diagnosis when applying the ASAS criteria for classification of axial 
spondyloarthritis, modified New York criteria for AS, CASPAR criteria for PsA or the 
new ACR RA criteria. All patients signed informed consent and the study had the 
approval of the local ethics committee. 
 
5.4.2.1.1. Outcome measures and statistics 
Predictors of outcome recorded include the HLA-B27 status (positive or 
negative), early intervention therapy with steroid injections and/or SSZ, number of 
swollen joints at the onset of the disease, disease duration from symptom onset and 
baseline RF. Anti-CCP status was recorded at follow-up as this test was not available at 
time of study design. Variables were analysed in a descriptive manner.  
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6. GLOBAL RESULTS 
 
6.1. MRI in the assessment of axial Psoriatic Arthritis and 
Spondyloarthritis 
 
In this part of the Thesis work we performed a cross-sectional audit of MRI 
scans of lumbar spine (L-spine) and sacroiliac (SI) joints. Using the semiquantitative 
Leeds Scoring System in which bone marrow oedema is graded from 0 to 3 according to 
severity of the lesions, MRI scans were scored independently by 2 expert readers who 
were blinded to the clinical characteristics of the patients. Concordant data from the 2 
readers were used to report on definite lesions. 
 
 Results:  
MRIs from 76 patients with comparable age ranges were categorized into 3 
groups: those from PsA patients, those from patients with non-radiographic axial SpA, 
and those from AS patients. HLA–B27 positivity was similar in PsA patients (10 of 33) 
and patients with non-radiographic axial SpA (10 of 24) and higher in AS patients (18 
of 19). Total MRI scores (L-spine plus SI joints) were higher in AS patients than in PsA 
patients (P = 0.025) or in patients with non-radiographic axial SpA (P = 0.007). A 
relationship was seen between the severity and extent of disease and HLA–B27 
positivity in PsA patients, which was comparable to that in AS patients. HLA–B27 
negative PsA patients had lower MRI scores than HLA–B27 positive PsA patients (P = 
0.03) and AS patients (P = 0.006), whereas scores were similar in HLA–B27–positive 
PsA patients and AS patients. Similarly, MRI scores of HLA–B27–negative patients 
with non-radiographic axial SpA were lower than those of AS patients (P = 0.01). 
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6.2. US in Spondyloarthritis and Psoriatic Arthritis 
6.2.1.  Ultrasonography of the Achilles enthesis bursa in early 
Spondyloarthritis 
6.2.1.1.  The importance of the bursa in spondyloarthritis: 
Achilles enthesis US in early Spondyloarthritis 
 
This part of the Thesis work is a transversal blind and controlled two-
dimensional (2D) and three-dimensional (3D) US study of Achilles enthesis bursa in 
Figure 23     Comparison of total numbers of inflammatory (bone marrow oedema) lesions on MRI of the 
lumbar spine and sacroiliac joint (SIJ) between patients with PsA, patients with AS, and patients with non-
radiographic axial Sp) in relation with HLA.B27 status (negative or positive): 
Data are shown as box plots 
Each box represents the 25th to 75th percentiles 
Lines inside the boxes represent the median  
Lines outside the boxes represents the 10th and the 90th percentiles 
Circles and asterisks indicates outliers 
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early SpA. Clinical outcome measures were collected. 
 
 Results: 
  Bilateral Achilles enthesis of 66 early SpA patients (34 women) and 46 control 
patients (23 asymptomatic healthy subjects and 23 rheumatoid arthritis [RA] patients) 
were analysed. Mean BASDAI, BASFI and BASRI-spine were 4.55±2.08, 2.16±1.95 
and 0.65±0.77, respectively. Mean erythrocyte sedimentation rate (ESR) was 
10.93±12.35 mm/h and C-reactive protein (CRP) was 6.46±10.09 mg/l. The κ -values 
for intra-reader agreement for 2D and 3D images and bursa measurement were 0.82 and 
0.98, respectively. Bursas were visualised in 89/132 SpA enthesis (67.4%) vs. 27/46 
enthesis (58.7%) of healthy controls (p<0.01), and 10/46 enthesis (21.7%) of RA 
controls (p<0.01). When the thicknesses of the bursas were analysed, the SpA group 
had a mean of 1.52±1.47 mm versus 0.76±0.76 mm in the healthy control group 
(p<0.0001), and 0.38±0.62 mm in the RA control group (p<0.0001). A positive 
likelihood ratio of 4.6 with a cut-off point of bursa >2 was found. No Doppler signal 
was detected in controls, but 6.6% of SpA Achilles enthesis had Doppler bursitis. Heel 
pain was more frequent when bursa was present (p<0.05). When Doppler was present, 
male predominance, HLA B27 positive, heel pain, and higher number of swollen joints, 
CRP levels, disease activity by the patient and BASDAI questions 2 and 3 achieved 
statistical significance (p<0.01). 
 
6.2.1.2. Achilles enthesis US as an outcome measure of disease 
activity in early Spondyloarthritis 
 
This part of the Thesis work is a longitudinal Achilles enthesis US study in 
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patients with early SpA. Achilles US examinations were performed at baseline, 6 and 12 
months and compared with clinical outcome measures collected at the baseline visit. 
 
 Results:  
Bilateral Achilles enthesis of 146 early SpA patients (68 women) were analysed. 
Basal mean BASFI, BASRI-spine, BASDAI and ASDAS were 2.44 (S.D. 2.05, range 
0-8), 0.67 (S.D. 0.74, range 0-3), 4.60 (S.D. 2.07, range 0-9.5) and 2.51 (S.D. 1.16, 
range 0-5), respectively. The mean ESR was 15.0 mm/h (S.D. 16.99, range 0-109) and 
the mean CRP was 8.67 mg/l (S.D. 16.98, range 1-90). At baseline, the Achilles 
Doppler signal and US structure alteration were significantly associated with higher 
CRP and ESR levels. Patients who had very high disease activity at baseline, as 
assessed by the ASDAS (>3.5), had a significantly higher Achilles total US score at 
baseline (P = 0.04), and ASDAS <1.3 predicted no Doppler signal at 6 and 12 months. 
Overall, the Achilles total US score was significantly higher in patients with higher 
levels of CRP (baseline P = 0.04, 6 months P = 0.006, 12 months P = 0.03) and ESR 
(baseline P = 0.02, 6 months P = 0.04, 12 months P = 0.005) at baseline. The Doppler 
signal at the baseline visit predicted a higher total US score at 6 and 12 months. 
 
6.2.2. Ultrasonography of the Sacroiliac joints in Spondyloarthritis  
 
This was a cross-sectional, blinded, case-control study of 108 cases divided into 
three groups: a) 53 SpA patients with inflammatory back pain (IBP); b) 28 SpA patients 
with no IBP; and c) 27 healthy mechanical lumbar pain subjects. Physical examinations 
of the SIJs were assessed as positive or negative in each SIJ and were used as the gold 
standard. SIJs were examined with CDUS and spectral Doppler, and the SIJs were 
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assessed as positive when both colour Doppler and the RI were less than the cut-off 
point within the SIJs area. 
 
 Results:  
A total of 108 cases (53 female; mean age 36 10 years old) were studied. The 
physical examination of the SIJs was positive in 38 patients (59 SIJs). Ultrasound 
detected Doppler signal within the SIJs in 37 cases (58 SIJs): 33 of them had 
symptomatic SpA (52 SIJs), 3 of them had asymptomatic SpA (5 SIJs), and 1 was a 
healthy control (1 SIJ). The accuracy of CDUS, when compared to physical SIJ 
examination, at the patient level in the overall group had a sensitivity of 70.3%, a 
specificity of 85.7%, a positive likelihood ratio of 4.9 and a negative likelihood ratio of 
0.36. For the spectral Doppler RI, with an optimal cut-off point ≤ 0.75, the sensitivity 
was 76.2%, and the specificity was 77.8%. 
 
6.2.3. Ultrasonography of the Nail and extensor tendon enthesis 
 
In this part of the Thesis work 86 psoriatic patients (169 nails) and 20 HC (40 
nails) were assessed with both the mNAPSI and US. The thickness of the nail plate, nail 
matrix region and adjacent extensor tendon were assessed and compared with physical 
examination findings.  
 
 Results: 
 A good agreement between clinical and sonographic nail findings was noted 
(kappa value = 0.52, p<0.0001). Entheseal thickening of the extensor tendon on US was 
more frequent in patients with clinical nail disease compared to patients without clinical 
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nail disease in both psoriasis and psoriatic arthritis (38 vs. 16%, p = 0.03, and 47 vs. 
19%, p = 0.008, respectively). Nail thickness, nail matrix and adjacent skin thickness 
were higher in psoriatic patients compared to HC. 
 
 
6.3. OCT and US in the assessment of nail disease in Psoriasis 
and Psoriatic Arthritis  
 
In this part of the Thesis work we compared OCT and US for nail disease 
assessment in 18 patients with psoriatic disease, with at least one involved nail and 12 
healthy controls were scanned using OCT; psoriatic patients also had an US scan (using 
a linear probe at 9–14 MHz). Nail and contour abnormalities were documented. Clinical 
onychopathy was scored independently using the modified Nail Psoriasis Severity 
Index.  
 
 Results: 
  Among 180 nails, 67.8% had clinical findings whereas 33.9% were abnormal by 
US and 44.4% had abnormalities on OCT. A positive OCT had a sensitivity and 
specificity of 44.4 and 95.8%, respectively, with a positive likelihood ratio of 10.7 for 
nail disease. OCT demonstrated 76.3% absolute agreement compared with clinical 
assessment and 65% with US. OCT detected subtle abnormalities in 12 clinically 
normal nails and in 41 nails with normal US findings. Conclusion:  These findings show 
that OCT has a potential for the systematic characterisation of psoriatic nail changes and 
could be useful in diagnosis and more objective assessment of treatment response. 
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6.4. Predictive factors in Psoriatic Arthritis and 
Spondyloarthritis 
6.4.1.  The link between enthesitis and arthritis in psoriatic: a 
switch to a vascular phenotype at insertions may play a 
role in arthritis development 
 
In this part of the Thesis work US with PD was used to test the hypothesis that 
subclinical enthesopathy in PsA was associated with an ‘inflammatory’ or vascular 
phenotype compared to that seen in psoriasis. 100 patients with a mean age of 46.3 
years (SD 15) (42 with psoriasis and 58 with PsA) and 23 matched healthy controls 
(HC) from two centres were included. 1230 lower limb entheses were scanned by 
ultrasonographers blinded to clinical details. Both inflammatory and chronic features of 
enthesopathy were scored. 
 
 Results:   
Psoriasis patients (with or without arthritis) were more likely to express a 
vascular phenotype, with higher inflammation-related enthesopathy scores than HC (for 
inflammation p<0.0001, for chronicity p=0.02, for total US scores p<0.0001). The PsA 
patients had higher ultrasound enthesopathy scores than psoriasis patients 
(inflammation p=0.04, chronicity p=0.02) and HC (inflammation p<0.0001, chronicity 
p=0.003). When symptomatic entheses were excluded, PsA patients still had higher PD 
scores than psoriasis patients ( p=0.003). Doppler positivity in at least one entheseal site 
was observed more frequently in PsA (21/58, 36.2%) versus psoriasis (4/42, 9.5%; 
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p=0.002). 
 
6.4.2. Long Term follow up of an early oligoarthritis cohort 
shows that early aggressive intervention leads to drug free 
remission after 10 years: results from the LoTO study 
 
This part of the Thesis work is a cross-sectional follow up of patients who 
participated in two previous interventional studies. Subjects were invited to either attend 
for a single study visit or a telephone consult. Presence/absence of any musculoskeletal 
symptoms and current diagnosis was recorded. Blood tests for inflammatory markers 
and radiographs of SIJs or any relevant joints were performed only if clinically 
indicated to establish a diagnosis 
if persistent clinical symptoms. 
 
 Results:  
Follow up data were available from 63.3% (n=74 patients) of the initial cohort 
(n=117 patients) [mean  SD disease duration at presentation 11.8  1.8 months; disease 
duration at follow up: 13  3 years]. Of these 74 patients, 63.51 % (n=47) had persistent 
arthritis since the end of the previous studies (19.5 % were RF positive; 33.3 % anti- 
CCP positive and 32.4% HLA-B27 positive). The majority (75%) had received joint 
steroid injections  sulfasalazine on the original study protocols. Oligoarthritis was still 
the predominant articular pattern in 68% of the patients at follow up and over a third of 
patients (36.5 %) were in clinical remission (4 % and 17.4 % RF and HLA-B27 positive 
respectively). 
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7. DISCUSSION 
 
7.1. Relation of HLA B27 status with extent of disease in MRI 
assessment of axial Psoriatic Arthritis 
In this part of the Thesis work we investigated the role of the HLA–B27 gene on 
the MRI phenotypes in PsA and axial SpA including AS. Our findings confirm that the 
HLA–B27 gene has a major effect on both the severity of axial lesions and the number 
of different distinct lesions. In accordance with previous studies, we have shown that 
the majority of patients with axial PsA and non-radiographic axial SpA are HLA–B27 
negative (99). In addition, we show that HLA–B27–positive axial PsA and AS have the 
same pattern of bone marrow oedema. Conversely, HLA–B27–negative axial disease 
including PsA has a much lower extent of bone marrow oedema. Collectively, these 
findings support the concept of the key role of the HLA–B27 gene as a determinant of 
the extent of osteitis in SpA. 
 
These findings have important implications for understanding SpA. There is 
now a link established between MRI-determined bone marrow oedema and subsequent 
disease progression at diseased segments. Given that symptomatic PsA has less bone 
marrow oedema, it might be expected that there is less diffuse spinal disease. Indeed, 
historical radiographic imaging studies have shown asymmetric, less severe disease in 
PsA compared to classic AS, but the studies in question did not note the HLA–B27 
status (2). It is interesting to note that AS, psoriasis, and PsA are all class I major 
histocompatibility complex–associated diseases. In the case of psoriasis, the HLA–
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Cw0602 gene is a severity factor for the extent of skin disease but does not appear to be 
linked to the joint disease. It seems that HLA–B27 is a marker for the extent of bone 
marrow oedema in SpA irrespective of the presence of skin psoriasis. Just as T cells 
appear to be associated with the dissemination of disease in HLA–Cw0602–positive 
skin psoriasis, T cells may be associated with the development of disease at different 
bony sites. This hypothesis has never been tested, and the role of the affected bone in 
SpA and the basis for disease in relation to HLA–B27 have not been evaluated at this 
site. 
 
These findings also have a practical aspect for consideration. The majority of 
PsA patients who were HLA–B27 negative were reported as having a normal MRI scan. 
This may reflect the fact that MRI may be insensitive at picking up subtle soft tissue 
changes at entheses (100). Our study has some limitations. First, this is a retrospective 
audit of MRI scans requested in daily clinical practice, and data on clinical outcomes 
such as the Bath Ankylosing Spondylitis Disease Activity Index (101) or Ankylosing 
Spondylitis Disease Activity Score (102) were not systematically collected to allow for 
a correlation with clinical symptoms. Previous studies on early inflammatory back pain 
have shown a higher level of disease activity as shown by clinical outcomes in patients 
with psoriasis (99), suggesting a possible role of psoriasis as an independent contributor 
to disease activity. 
 
Taken together, these results suggest a role for HLA–B27 and psoriasis as partly 
independent contributors to inflammation and disease activity in axial PsA. Second, the 
sample size was small, which represents an important limitation to conducting a 
multivariate analysis of the data. Third, only the lumbar portion of the spine in addition 
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to the SI joints was imaged as opposed to the whole spine. Ideally, the whole spine 
should have been imaged to allow for the assessment of cervical and thoracic sites 
where a significant proportion of lesions may have been missed. Further, we have 
looked at inflammatory bone lesions only as represented by bone marrow oedema, but a 
“positive” MRI result reflecting disease may need to incorporate other features of 
structural change such as fatty degeneration, sclerosis, or erosions.  
 
The presence of structural lesions in the absence of inflammation would help us 
to understand why axial PsA is indeed more asymptomatic than AS and can go largely 
undiagnosed. Larger, prospective MRI studies of the whole spine with associated 
genotypes are needed to confirm these results. 
 
7.2. US in Spondyloarthritis and Psoriatic Arthritis 
7.2.1. Ultrasonography of the Achilles bursa in patients with 
early Spondyloarthritis 
7.2.1.1. US of the bursa-synovial of the Achilles enthesis in early SpA 
The purpose of this part of the Thesis work was to determine whether the US 
recognition of bursa affectation on enthesis could be relevant as elemental lesion in the 
concept of entheseal damage and enthesitis definition in SpA. While the link between 
enthesitis and osteitis in SpA has been clarified in recent studies that demonstrate a 
close functional integration of the enthesis with the neighbouring bone (11), the 
connection between enthesitis and bursal-synovitis remains a subject of debate (12). 
OMERACT’s enthesopathy definition does not include bursa affectation as previously 
mentioned in the introduction. The quality of diagnostic tests used for the care of 
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patients is not judged only by their analytical characteristics, but mainly for their ability 
to distinguish between alternative states of health. 
 
For the bursa US to be used in routine medical practice, this diagnostic test must 
reduce uncertainty towards a specific diagnosis and contributes to accurate therapeutic 
decision making.  
 
Our study tries to assess the prevalence and relevance of the bursa-synovial 
lesión in SpA using the Achilles enthesis as a model. In this sense, similar to previous 
data, our findings demonstrate that retrocalcaneal bursa can be detectable by US in 
normal subjects (30, 103). However, this study shows a significant increase of Achilles 
bursa presence and thickness in SpA patients compared to controls (healthy/mechanical 
controls and RA controls). Furthermore, when bursa’s thickness was measured, our 
results showed an increase in SpA patients with statistical significant differences. 
 
A cut-off point of bursa ≥2mm had a positive likelihood ratio of 4.6 in front of 
healthy/mechanical subjects. A likelihood ratio between 2 and 5 generates small, but 
sometimes important changes in probability. A striking finding is the relatively low 
prevalence and thickness of bursa in RA control group (21.7% in RA control group 
versus 58.7% in healthy controls; p <0.01). This control population was composed by 
RA patients all treated with disease modifying anti-rheumatic drugs without advanced 
deformities, and low disease activity. Another possible explanation could be bursa 
presence of mechanical origin in healthy control population related with overuse. 
 
In agreement with what has been shown by other authors, the presence of 
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Doppler signal seems to have a high significance in the correct classification of SpA 
patients (14, 24, 35, 36). In our study, Doppler signal is associated with other clinical 
measures accepted for assessment of SpA disease activity (C-reactive protein, heel pain, 
patient VAS for pain and global disease activity evaluation, number of swollen joints 
and BASDAI 3), but not with axial question of BASDAI, it even had a negative 
association with spine pain (BASDAI 2). The association with the number of swollen 
joints, BASDAI 3 and C-reactive protein is in agreement with the idea that bursal-
synovial specific factors could trigger innate immune responses and may be pivotal 
players in the phenotypic expression of SpA, as suggested by the synovio-entheseal 
complex concept proposed by McGonagle et al. (12, 27, 28). In this sense, and 
supporting the idea of the importance of the participation of the synovial bursal tissue in 
enthesis damage, previous reported data have demonstrated that erosions typically occur 
in the bursal proximal portion of the enthesis in SpA patients, possibly establishing a 
link between these lesions (13, 104).  
 
Additionally, a longitudinal study of patients treated with TNF-alpha blocking 
agents demonstrated that the only elemental lesions that achieved a significant reduction 
after the treatment were entheseal hypoechogenicity and/or thickening, bursa and 
Doppler signal (88, 105). This reinforces the possible importance of the introduction of 
these elementary lesions in future scoring systems for activity, damage, or follow-up 
purposes. 
 
A limitation of this study was the low number of patients and controls 
weakening the statistical power of our results. Another limitation is the low sensitivity 
of bursa in grey scale, which reduces the value of bursa in enthesis US examination, but 
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this is not different from other elemental lesions included in enthesopathy definition 
such as thickness that had less contribution (36). Probably no one lesion, as bursa 
presence, but the combination of entheseal lesions improve the knowledge of the SpA 
enthesis pathological process. 
 
The Doppler presence seems to have a high diagnostic value for SpA, but has 
the limitation of its low prevalence. One possible explanation for the low prevalence of 
Doppler signal could be related with the low vascularisation flow of the enthesis. Even 
in other published data by expert groups a similar low prevalence of Doppler signal was 
found (36, 88, 105) (31,34, 35). In this sense, it is remarkable that the analysis of 
Doppler presence taking into account clinical variables achieved statistical significance. 
 
7.2.1.2. US examination for the assessment of disease activity in early SpA 
In general, assessment of patient disease activity is always difficult, particularly 
in SpA. The concept of disease activity, a reflection of the underlying inflammation, 
encompasses a wide range of measures and domains. For its assessment, we can use the 
patient and the physician perspective, single disease activity parameters (e.g. ESR or 
CRP) or a composite index. It is likely that a composite disease activity index will 
capture multiple important aspects of disease activity and better represent the true 
disease state. The BASDAI, probably the most commonly used score in clinical 
practice, is composed of six domains with a high level of face validity; however, it 
represents only the subjective perspective of the patient (106). To reduce the well-
known limitations of subjective components based on patient perspective, ASAS has 
developed the ASDAS, with the hypothesis that a better selection of patient perspective 
components and an objective laboratory parameter will improve the composite score 
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(102, 107). 
 
The enthesis, which is one of the more important targets in the pathogenesis of 
SpA, is undervalued in the assessment of disease activity. The inclusion of enthesitis as 
an outcome measure in SpA patients is represented in the BASDAI in question 4 but not 
in the ASDAS. The ASAS core set for clinical record keeping and for disease-
controlling anti-rheumatic treatments validated an enthesitis score, such as the 
Maastricht Ankylosing Spondylitis Enthesitis Score (MASES), San Francisco or Berlin  
(108). However, it is accepted that clinical examination lacks sensitivity and specificity 
for enthesitis detection and that imaging techniques such as US can be efficiently used 
for this purpose. This is why a large number of studies have been published on US 
entheseal alterations in SpA diseases in recent years (14, 24, 35, 36). 
 
Disease activity in SpA patients is most likely related to at least three aspects: 
axial, synovial and entheseal involvement. Any composite score that is used as an 
outcome measure in SpA should include these domains. Our study explores a new 
perspective not previously reported about the construct validity of enthesis US as a 
possible disease activity outcome measure in SpA. The question remains as to how US 
findings are related to other well-known measures of disease activity and their 
relevance. In this sense, our results are exciting because they show that basal ESR and 
CRP are higher in patients with an enthesis Doppler signal and that higher basal ESR, 
CRP and ASDAS predicted a higher Doppler signal (a US alteration accepted as 
representative of inflammation) 6 months later. This seems to represent a connection 
between classic biochemical or immunological aspects of inflammation and Doppler 
signal, not only simultaneously, but also in future months. Patients with higher ESR and 
 132
CRP also had higher total Achilles scores at the baseline, 6 and 12 month examinations, 
which could be a predictor of poorer prognosis in these patients. A similar association 
was also found at baseline in patients with higher ASDAS. Remarkably, patients with 
inactive disease (ASDAS <1.3) at baseline had no Doppler signal at 6 and 12 months, 
indicating a negative predictive value. Furthermore, the Doppler signal at the baseline 
visit predicted a higher total US score at 6 and 12 months. Interestingly, at baseline, 
patients with ASDAS <2.1 had higher total Achilles scores when compared with 
patients with ASDAS <3.5. One possible explanation for this could be that the ASDAS 
measures other domains besides enthesitis, so axial or peripheral arthritis could 
influence the results. Nevertheless, during follow-up, the total Achilles score decreased 
to a greater extent in the group with higher ASDAS (ASDAS >3.5 vs ASDAS <3.5), 
which is likely related to more aggressive therapies (including biologic agents) in 
patients with higher levels of disease activity and the relative lack of efficacy of the 
treatment in patients with lower disease activity. These findings reinforce the potential 
use of enthesis US for assessment of disease progression and prognosis. Nonetheless, 
the BASDAI does not show significant differences between different cut-offs for US 
lesions or Doppler signal when verified with the ASDAS. These results seem to indicate 
that the ASDAS better reflects entheseal disease activity than does the BASDAI. 
 
One limitation of this study is the exploration of a single peripheral enthesis. The 
challenge will be to verify if another single enthesis or a composite US entheseal index 
has better validity than the Achilles tendon by itself. Even so, the consistency of our 
results using just one enthesis is remarkable. Another limitation of our study is that we 
had incomplete data for follow-up in the longitudinal study; however, data for at least 
80 patients remained for each variable. Another limitation is that the study was 
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conducted by only one researcher with a US machine, thus these findings need to be 
replicated by others. 
7.2.2. Ultrasonography of the Sacroiliac joints in 
Spondyloarthritis 
Currently, there is little available knowledge on the use of ultrasound on the SIJs 
or the applicability of US in the diagnosis and monitoring of SpA. In this sense, 
conducting new studies in this field is important. Previous studies have provided initial 
evidence of the validity of SIJ US (37-43). Analyses of these data showed that US could 
provide an opportunity to assess the SIJs. There have been different research end points 
used in these studies, using grayscale mode, colour Doppler, ultrasound-enhanced 
media and RI. Contrast-enhanced studies have shown very good results in terms of 
validity, but it is an invasive technique that increases the time and cost of examinations 
and can lead to adverse events in patients. 
 
To determine the real possibilities for the use of US SIJ examinations in clinical 
practice, it is interesting to note that an LR greater than 10 or less than 0.1 is considered 
to be sufficiently strong evidence to confirm or disprove, respectively, a diagnosis in 
most circumstances. LRs of 5-10 and 0.1-0.2 generate moderate shifts in pre-test and 
post-test probabilities, respectively, and LRs of 2-5 and 0.5-0.2 generate smaller (but 
sometimes important) changes in these probabilities. In our study, the positive LR 
achieved by US in the SIJs was 4.9, meaning that US could be a useful test to assess 
active sacroiliitis in clinical practice. This result was better than the previously reported 
data of 4.25 (38) and 2.67 (40) but was lower than the results when enhanced ultrasound 
media were used, for which the positive LR was 6.71 (38). 
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Zhu et al, (43) studied the complex appearance of vascularity of the SIJs in AS 
and commented that most of the colour flow signs corresponded to venous flow in 
active AS patients. In our study, spectral Doppler tracing was obtained to confirm that 
each CDUS signal represented a true arterial or venous flow pattern, and the 
inflammatory patterns were also checked using the RI to improve the accuracy. In the 
evaluation of the RI, our study had similar RI results to those achieved by previous 
publications (38, 40, 43), demonstrating statistically significant differences between 
SpA patients and controls. However, we went one step further with the calculation of 
the better cut-off for the RI (≤0.75) to differentiate clinical activity from normality 
using flow pattern assessment. 
 
Furthermore, the presence of IBP is a key symptom of axial involvement in 
SpA, and it is present in the majority of patients (34). Therefore, we studied whether 
CDUS assessment could answer a relevant question in clinical practice, i.e., whether 
IBP is related to the diagnosis of SpA. In our study, the presence of Doppler signals in 
the SIJs resulted in a high positive LR value when compared to patients with or without 
IBP. The combination with IBP increased the post-test probability of SI joint US 
examination to a positive LR of 8.4; thus, CDUS of the SIJs could be of relevance in the 
detection of active sacroiliitis and in the diagnosis of SpA, but these data need to be 
confirmed in further studies. 
 
There were some limitations to our study. First, an increased body mass index 
can reduce the sensitivity of CDUS. It was difficult to detect CDUS signals with our US 
equipment when the SIJs were deeper than 4 cm. This fact could have resulted in some 
false negatives cases. Second, we compared US results to physical examination as the 
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gold standard. There are many physical examination tests for the SIJs, and all of them 
have been advocated as useful tools in identifying patients with SIJ pain; however, none 
of the available SIJ tests appears to be clearly superior to the others (109). To reduce 
this limitation, we used several of these tests. Moreover, physical examination has been 
accepted as the gold standard in previous studies (40, 43), although it is probably not 
the actual gold standard. Histopathology is the most accurate gold standard, but it is 
difficult to perform. MRI is accepted as a good technique to assess sacroiliitis, but its 
correlation with histopathology has a relative lack of sensitivity (110). CDUS can also 
be used to perform US-guided sacroiliac joint injection in the treatment of sacroiliitis  
(111) and to detect the changes of sacroiliitis and peripheral enthesitis in AS patients 
under biologic therapy (112). 
 
7.2.3. Ultrasonography of the Nail and the extensor tendon 
enthesis in psoriasis and Psoriatic Arthritis 
This is the first study using US to assess the entire nail apparatus including the 
nail plate and nail matrix region, where it is now known that the nail is integrated with 
the skeleton (49). Both US and clinical examination were broadly similar for the 
assessment of the nail plate region. In the evaluation of the nail matrix region we noted 
an association between extensor tendon enthesopathy and nail disease. This 
enthesopathy was specifically associated with nail disease but not clinical PsA. These 
findings are relevant for the development of US for the assessment of the nail disease 
and also point towards the importance of the enthesis in nail involvement. 
 
These findings have implications for a better understanding of nail disease in 
psoriasis. The link between enthesopathy on US and clinical nail disease was not 
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confined 
to pitting, a recognised matrix-specific abnormality, but was also seen with onycholysis 
(thought to be a nail plate lesion) which therefore would not be expected to be related to 
extensor tendon disease. These findings raise the possibility that nail pain and loss of 
function seen in the dermatological setting may in part be related to microenthesopathy-
related pain. The relevance of these changes for the development of PsA and their 
relevance for the prognosis of nail disease awaits further study. 
 
Another noteworthy finding of the present study was that the DIP enthesopathy 
was associated with both epidermal thickening and dermal oedema. This is interesting 
since it suggests a very close link between the pathology in the skin and the adjacent 
enthesis and to the best of our knowledge has not being recognised before. Perhaps the 
skin changes may be secondary to extension of the inflammatory processes to the 
adjacent dermis with secondary epidermal changes, or they may reflect common 
mechanical stretching responses to the skin and enthesis during finger flexion. 
 
There are some potential limitations to this study. As with all US studies on 
psoriasis, it is not technically possible to be completely blinded to the skin findings if 
the patient has very severe disease. We tried to avoid this situation by avoiding 
conversation between the patient and the ultrasonographer about their disease and by 
having the room completely darkened from the beginning of the assessment. 
 
In conclusion, this study confirms that US is helpful to objectively assess 
psoriatic nail disease and compares favourably with clinical assessment. Given that only 
superficial changes can be detected by physical examination, US proved to be 
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informative in the nail matrix and adjacent extensor tendon region. In particular the US 
findings in this study showed a link between extensor tendón enthesopathy and nail 
disease. This supports the concept that nail disease in psoriasis is more than skin deep, 
and is linked to enthesopathy. This has broad implications for further studies into nail 
disease in psoriasis. 
 
7.3. OCT and US in the assessment of nail disease in Psoriasis 
and Psoriatic Arthritis 
The purpose of this part of the Thesis work was to evaluate OCT in comparison 
to US with respect to nail disease in psoriasis and PsA. Based on our findings, we 
suggest that OCT has the potential to become the modality of choice for imaging the 
nail in subjects with psoriasis-related nail disease. It seems likely that OCT could permit 
a more objective imaging assessment of nail disease and may be helpful in diagnosis 
and assessment of treatment responses. 
 
The OCT technique allows a more detailed assessment of the nail structure than 
has previously been possible. We have shown that pitting was remarkably superficial 
but that leuconychia was in the middle layer of the nail. We also describe a number of 
additional features that are readily appreciated on OCT. Our preliminary findings herein 
showed no obvious differences between PsA and psoriasis. 
 
Little data were available previously on the use of OCT in assessing nail disease. 
Two small OCT studies in HCs described the appearance of the nail using OCT; these 
mentioned leuconychia with a similar pattern to that which we have noted (57, 113). 
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One other study assessed patients with a variety of nail disorders (114). This included 
two patients with psoriatic nail disease, with the first description of the appearance of 
nail pitting. 
 
Our results also indicate that OCT is capable of detecting subclinical nail 
involvement in some psoriasis and PsA cases compared to healthy subjects. This raises 
the possibility that it could be used clinically in the rheumatology setting to look for nail 
changes in patients without obvious psoriasis in the presence of an undifferentiated 
seronegative arthritis. On the other hand clinical assessment was more positive than 
OCT, and whether OCT detects more severe lesions that may progress needs fur ther 
follow-up. It is possible that OCT could have a diagnostic role and serve as an objective 
and potentially quantifiable tool to assess nail disease in psoriasis, which will be 
addressed in prospective, larger studies. 
 
A potential technical limitation of this work was that the mNAPSI score was 
performed independently by a clinical assessor and that quite often multiple lesions 
were encountered in the same nail, including pitting, onycholysis and leuconychia. 
These nails were invariably reported as abnormal on OCT but it was therefore not 
possible to correlate individual lesions between the OCT and the mNAPSI. Another 
relevant issue to consider is that the resolution of US is improving all the time and that 
with higher-resolution probes, it may be that the sonography will also prove to be useful 
for the visualisation of the nail. Further work in this regard is planned. Research into the 
potential uses of OCT in this field is ongoing in several centres.  
 
Recent studies have shown some potential for the use of OCT in the diagnostic 
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assessment of fungal nail disease, with good sensitivity but lower specificity than other 
methods (114). In a separate study, a change in nail thickness has been demonstrated 
using OCT after exposure to water (115). Clearly, the use of OCT in the differential 
diagnosis between psoriatic and other types of nail disease merits further assessment. 
 
In conclusion, this work shows that OCT may become the imaging modality of 
choice for the assessment of nail disease in psoriasis, including use as an objective 
measure to assess response to therapy. 
 
7.4. Predictive factors in Psoriatic Arthritis and Spondyloarthritis 
7.4.1. Enthesis US as an imaging biomarker in psoriasis and 
psoriatic arthritis 
This study showed that the frequency of enthesis-related PD change was 
significantly higher in PsA compared to psoriasis even when only sites of asymptomatic 
enthesopathy were evaluated in PsA. Moreover, the frequency of subclinical enthesopa- 
thy was significantly higher in PsA compared to psoriasis. The results of this cross-
sectional study suggest that there may be a trend towards increased entheseal thickening 
with subsequent vascular changes representing a step in the progression towards PsA in 
psoriasis cases. This will require confirmation in a longi- tudinal study. It is noteworthy 
that abnormal patterns of vascularity have been reported in psoriatic arthritis synovium 
both by arthroscopic inspection and by histological assessment (116, 117). Likewise, 
prominent vascular changes have been reported in skin disease and at the nail matrix in 
psoriasis (118, 119). Furthermore, normal entheseal insertions are sites prone to 
microdamage and in the course of physiological tissue repair at such sites prominent 
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histological evidence of vascular changes is seen even in healthy individuals (29). In 
this study we found a high prevalence of enthesophytes in the HC. Enthesophytes are 
not specific to enthesitis and may be related to mechanical forces. This finding also 
reflects the high sensitivity of ultrasound to detect these changes. 
 
In this study, we found no entheseal PD signals in the HC group. The majority 
of the literature supports the absence of ultrasound-detectable blood flow in normal 
individuals (120), PD changes have been reported in a few cases (36). This raises the 
possibility of using Doppler signals for early diagnosis, although this would need to be 
demonstrated in prospective trials. 
 
This study was performed in two different European populations by different 
sonographers, which raises issues about its reliability and general applicability. 
However, both study populations exhibited identical trends in patterns of disease. 
Likewise, the sonographers met and agreed on standard sonographic criteria for 
enthesitis and the interobserver agreement was quite high. 
 
Taken together, these findings now need to be applied in a large inception cohort 
of psoriasis patients to ascertain whether they define the subgroup that will be likely to 
evolve into PsA in the following months and years. In that regard, we have previously 
used US to show a high frequency of subclinical entheseal involvement in patients 
presenting with psoriasis but without clinically evident arthritis (83). After following 
this cohort for 3.5 years we have seen a link between subclinical enthesopathy in 
patients with psoriasis and the future development of PsA (121). 
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In conclusion, this study shows that the degree of systemic subclinical 
enthesopathy is much greater in PsA compared to psoriasis. Of particular note, the 
difference in vascular changes in PsA compared to psoriasis might have implications for 
determining the likelihood of a given patient progressing to PsA. This will form the 
basis for future studies. 
7.4.2. Ten years follow-up of an Early Oligoartrhitis Cohort 
Oligoarthritis is a common condition with a variable outcome that typically 
affects young people and can lead to high morbidity. However long term follow up data 
are sparse (122, 123). Our original reports (92, 93) showed that prompt intervention in 
early oligoarthritis led to significant improvements in clinical outcomes when compared 
to a more conservative approach using NSAIDs. The aim of the current project was to 
report on the long-term outcome of an inception cohort of patients, with early onset of 
oligoarthritis to identify prognostic factors.  
Our results show that up to 65.4 % and 5,40% of the patients that remained 
asymptomatic at follow up had received joint steroid injections or SSZ respectively in 
the previous studies, but when we compare this to patients who had persistent arthritis 
over the years there is no statistically significant difference. One explanation for this 
could be the small numbers of patients followed up. We believe that the real percentage 
of patients in remission among this group could be much higher than the 36% found, 
and that this may be the reason why subjects have not remained under follow up. This is 
an important limitation of our study but common with follow up of longitudinal cohorts. 
A substantial number of subjects from our initial cohort were young adults attending 
university who represent a highly mobile group and we were unable to track them down 
after the years.  
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Only a few studies have reported long-term outcome in uSpA or oligoarthritis 
for prognostic factors. Sampaio-Barros, et al (122) published data on 5 to 10 years 
follow up for 105 and 42 uSpA patients respectively with a mean disease duration at 
onset of 5 years. Huerta-Sil, et al (123) reported the findings in 50 patients with 
peripheral arthritis and inflammatory back pain with disease duration of 5.4 years after 
3-5 years. In Kumar’s long term follow up (11 years) study (124), 22 patients, all of 
them with inflammatory back pain and a high proportion of peripheral arthritis, had a 
mean disease duration at onset of 8 months. In a recent multicentre cohort study (125) 
440 children with juvenile idiopathic arthritis were followed for up to 7 years after 
disease onset. By comparison, the Leeds Cohort represents a unique inception group by 
virtue of its very short symptom duration at the time of clinical presentation which was 
of 10 weeks (median) on the first study (92) and 16 weeks in the second study (93). In 
addition, follow up averaged 14 years in some cases, which makes this the largest long 
term study of patients presenting with oligoarthritis. 
Another limitation of our study comes from the fact that only 29.73% of the 74 
patients attended for a hospital visit with the majority feeling there was no need for it as 
they were completely asymptomatic. Indeed, 27 patients (36.49%) were assessed via 
telephone consult and in the remaining (32.43%) data were collected from clinical notes 
as these were still regular hospital attenders.  
In conclusion, ten-year follow up of an early oligoartritis cohort shows that over 
a third of patients attending for review are in drug free clinical remission. The majority 
had received joint steroid injections  SSZ early on in their disease onset. These results 
can throw important insights into the pathogenesis of this condition and provide useful 
guidance for clinicians managing these patients. 
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8. CONCLUSIONS  
 
8.1. English 
1. HLA–B27–related active axial PsA shows an extent of inflammation on MRI 
comparable to that of AS and superior to that of HLA–B27–negative PsA. The 
results suggest that this subgroup of PsA shares common etiopathogenic 
mechanisms of disease with AS and may carry a comparable disease burden. 
2. US findings at retrocalcaneal bursa level have low sensitivity, but could have 
an important contribution in differentiating patients with early SpA (positive 
likelihood ratio of 4.6). Its inclusion in future new consensus definition of 
enthesitis should be evaluated. 
3. Doppler US is significantly associated with other commonly used disease 
activity measures and seems to be a valid tool for assessing entheseal 
inflammation in SpA patients. As a disease status measure, it seems that, 
compared with the BASDAI, the ASDAS reflects entheseal inflammation 
better. This study supports the construct validity of enthesis US and supports its 
role in the assessment of disease activity in patients with early SpA. 
4. CDUS is a promising imaging technique for the detection of active sacroiliitis 
and could be a less expensive and easier-to-apply alternative method to MRI 
for detecting inflammation secondary to increased SIJ vascularization. Our 
results showed good sensitivity and high specificity of CDUS combined with 
RI, especially when they were associated with IBP. CDUS might be as cost-
effective a technique as an initial imaging assessment in the study of 
inflammatory lower back pain. 
5. US and clinical findings show good correlation for the assessment of the nail in 
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psoriatic disease. The demonstration of extensor tendon enthesopathy in both 
psoriasis and PsA supports the importance of enthesopathy in nail disease 
pathogenesis whether or not clinical arthritis is present. 
6. OCT has a potential for the systematic characterisation of psoriatic nail changes 
and could be useful in diagnosis and more objective assessment of treatment 
response. 
7. Ultrasound appearances of subclinical enthesitis in psoriasis differ from the 
subclinical enthesitis in PsA, with PsA patients having more PD. This is 
suggestive of a more inflammatory or vascular process in PsA, and offers 
potentially novel insights into the progression from skin to joint disease in 
psoriasis. 
8. Ten-year follow up of an early oligoarthritis cohort shows that over a third of 
patients attending for review are in drug free clinical remission following an 
initial early treatment. 
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8.2. Spanish 
1. Los pacientes HLA-B27 positivo con artritis psoriásica axial activa presentan un 
grado de inflamación en la resonancia magnética comparable al de los pacientes 
con espondilitis anquilosante y superior al de los pacientes con artritis psoriásica  
HLA-B27 negativo. Los resultados sugieren que este subgrupo de artritis 
psoriásica comparte mecanismos etiopatogénicos de la enfermedad con la 
espondilitis anquilosante y que puede presentar una afectación de la enfermedad 
similar. 
2. Los hallazgos ecográficos obtenidos del estudio de la bursa retrocalcánea tienen 
baja sensibilidad, pero podrían tener una importante papel en la diferenciación 
de los pacientes con espondiloartritis precoz (razón de verosimilitud positiva de 
4.6). Debería considerarse la inclusión de la bursa en la futura definición de 
consenso de la entesitis. 
3. La presencia de señal Doppler en la ecografía de entesis se asocia 
significativamente con otras medidas de actividad de la enfermedad usadas 
habitualmente en pacientes con espondiloartritis. Como medida de actividad de 
de la enfermedad, parece que, en comparación con el BASDAI, el ASDAS 
refleja mejor la inflamación entesítica. Este estudio apoya la validez de 
constructo de la ecografía de entesis y apoya su papel en la valoración de la 
actividad de la enfermedad en pacientes con espondiloartritis precoz. 
4. La ecografía Doppler color es una técnica de imagen prometedora para la 
detección de sacroileítis activa y podría ser un método alternativo menos costoso 
y más fácil de aplicar a la resonancia magnética para detectar inflamación en las 
articulaciones sacroilíacas. Nuestros resultados muestran una buena sensibilidad 
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y alta especificidad de la ecografía Doppler color en combinación con el índice 
de resistividad, especialmente cuando se asocia con dolor lumbar inflamatorio. 
La ecografía Doppler color puede ser coste eficiente como técnica de imagen de 
valoración inicial en el estudio de los pacientes con dolor lumbar inflamatorio. 
5. Los hallazgos clínicos y ecográficos muestran una buena correlación para la 
evaluación ungueal en la psoriasis. La demostración de la entesopatía del tendón 
extensor, tanto en la psoriasis como en la artritis psoriásica, apoya la 
importancia de la entesis en la patogénesis de la enfermedad ungueal, con o sin 
artritis clínica asociada. 
6. La tomografía óptica de coherencia tiene un gran potencial para la 
caracterización sistemática de lesiones en las uñas de pacientes con psoriasis y 
podría ser útil en el diagnóstico y la valoración de respuesta al tratamiento. 
7. Los hallazgos ecográficos de la entesitis subclínica en pacientes con psoriasis 
difieren de los encontrados en la entesitis subclínica de los pacientes con artritis 
psoriásica, encontrándose más señal PD en estos últimos. Esto es sugestivo de 
un proceso inflamatorio o vascular mayor en la artritis psoriásica, y ofrece 
perspectivas novedosas en el conocimiento de la progresión de la afectación 
cutánea a la afectación articular. 
8. El seguimiento a diez años de una cohorte de oligoartritis temprana muestra que 
más de un tercio de los pacientes están en remisión clínica y sin tratamiento tras 
una intervención terapéutica precoz inicial. 
 
 
 
 147
9. REFERENCES 
1. Gladman DD, Brubacher B, Buskila D, Langevitz P, Farewell VT. Differences in the expression 
of spondyloarthropathy: a comparison between ankylosing spondylitis and psoriatic arthritis. Clin Invest 
Med. 1993;16(1):1-7. 
2. Helliwell PS, Hickling P, Wright V. Do the radiological changes of classic ankylosing 
spondylitis differ from the changes found in the spondylitis associated with inflammatory bowel disease, 
psoriasis, and reactive arthritis? Ann Rheum Dis. 1998;57(3):135-40. 
3. Rudwaleit M, Khan MA, Sieper J. The challenge of diagnosis and classification in early 
ankylosing spondylitis: do we need new criteria? Arthritis Rheum. 2005;52(4):1000-8. 
4. Williamson L, Dockerty JL, Dalbeth N, McNally E, Ostlere S, Wordsworth BP. Clinical 
assessment of sacroiliitis and HLA-B27 are poor predictors of sacroiliitis diagnosed by magnetic 
resonance imaging in psoriatic arthritis. Rheumatology (Oxford). 2004;43(1):85-8. 
5. Puhakka KB, Jurik AG, Schiottz-Christensen B, Hansen GV, Egund N, Christiansen JV, et al. 
MRI abnormalities of sacroiliac joints in early spondylarthropathy: a 1-year follow-up study. Scand J 
Rheumatol. 2004;33(5):332-8. 
6. Marzo-Ortega H, McGonagle D, O'Connor P, Hensor EM, Bennett AN, Green MJ, et al. 
Baseline and 1-year magnetic resonance imaging of the sacroiliac joint and lumbar spine in very early 
inflammatory back pain. Relationship between symptoms, HLA-B27 and disease extent and persistence. 
Ann Rheum Dis. 2009;68(11):1721-7. 
7. McGonagle D, Marzo-Ortega H, O'Connor P, Gibbon W, Pease C, Reece R, et al. The role of 
biomechanical factors and HLA-B27 in magnetic resonance imaging-determined bone changes in plantar 
fascia enthesopathy. Arthritis Rheum. 2002;46(2):489-93. 
8. Bennett AN, McGonagle D, O'Connor P, Hensor EM, Sivera F, Coates LC, et al. Severity of 
baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back 
pain predict radiographically evident ankylosing spondylitis at eight years. Arthritis Rheum. 
2008;58(11):3413-8. 
9. van Onna M, Jurik AG, van der Heijde D, van Tubergen A, Heuft-Dorenbosch L, Landewe R. 
HLA-B27 and gender independently determine the likelihood of a positive MRI of the sacroiliac joints in 
patients with early inflammatory back pain: a 2-year MRI follow-up study. Ann Rheum Dis. 
2011;70(11):1981-5. 
10. de Vlam K, Lories RJ, Luyten FP. Mechanisms of pathologic new bone formation. Curr 
Rheumatol Rep. 2006;8(5):332-7. 
11. Lories RJ, Luyten FP, de Vlam K. Progress in spondylarthritis. Mechanisms of new bone 
formation in spondyloarthritis. Arthritis Res Ther. 2009;11(2):221. 
12. Benjamin M, McGonagle D. Histopathologic changes at "synovio-entheseal complexes" 
suggesting a novel mechanism for synovitis in osteoarthritis and spondylarthritis. Arthritis Rheum. 
2007;56(11):3601-9. 
13. McGonagle D, Wakefield RJ, Tan AL, D'Agostino MA, Toumi H, Hayashi K, et al. Distinct 
topography of erosion and new bone formation in achilles tendon enthesitis: implications for 
understanding the link between inflammation and bone formation in spondylarthritis. Arthritis Rheum. 
2008;58(9):2694-9. 
 148
14. D'Agostino MA, Said-Nahal R, Hacquard-Bouder C, Brasseur JL, Dougados M, Breban M. 
Assessment of peripheral enthesitis in the spondylarthropathies by ultrasonography combined with power 
Doppler: a cross-sectional study. Arthritis Rheum. 2003;48(2):523-33. 
15. Balint PV, Kane D, Wilson H, McInnes IB, Sturrock RD. Ultrasonography of entheseal 
insertions in the lower limb in spondyloarthropathy. Ann Rheum Dis. 2002;61(10):905-10. 
16. Alcalde M, Acebes JC, Cruz M, Gonzalez-Hombrado L, Herrero-Beaumont G, Sanchez-
Pernaute O. A sonographic enthesitic index of lower limbs is a valuable tool in the assessment of 
ankylosing spondylitis. Ann Rheum Dis. 2007;66(8):1015-9. 
17. Gandjbakhch F, Terslev L, Joshua F, Wakefield RJ, Naredo E, D'Agostino MA, et al. Ultrasound 
in the evaluation of enthesitis: status and perspectives. Arthritis Res Ther. 2011;13(6):R188. 
18. Delle Sedie A, Riente L, Filippucci E, Scire CA, Iagnocco A, Gutierrez M, et al. Ultrasound 
imaging for the rheumatologist XXVI. Sonographic assessment of the knee in patients with psoriatic 
arthritis. Clin Exp Rheumatol. 2010;28(2):147-52. 
19. Rudwaleit M, van der Heijde D, Landewe R, Akkoc N, Brandt J, Chou CT, et al. The 
Assessment of SpondyloArthritis International Society classification criteria for peripheral 
spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis. 2011;70(1):25-31. 
20. Gossec L, Smolen JS, Gaujoux-Viala C, Ash Z, Marzo-Ortega H, van der Heijde D, et al. 
European League Against Rheumatism recommendations for the management of psoriatic arthritis with 
pharmacological therapies. Ann Rheum Dis. 2012;71(1):4-12. 
21. Sivas F, Mermerci Baskan B, Erkol Inal E, Akbulut Aktekin L, Barca N, Ozoran K, et al. The 
relationship between enthesitis indices and disease activity parameters in patients with ankylosing 
spondylitis. Clin Rheumatol. 2009;28(3):259-64. 
22. Kamel M, Eid H, Mansour R. Ultrasound detection of heel enthesitis: a comparison with 
magnetic resonance imaging. J Rheumatol. 2003;30(4):774-8. 
23. Wakefield RJ, Balint PV, Szkudlarek M, Filippucci E, Backhaus M, D'Agostino MA, et al. 
Musculoskeletal ultrasound including definitions for ultrasonographic pathology. J Rheumatol. 
2005;32(12):2485-7. 
24. de Miguel E, Cobo T, Munoz-Fernandez S, Naredo E, Uson J, Acebes JC, et al. Validity of 
enthesis ultrasound assessment in spondyloarthropathy. Ann Rheum Dis. 2009;68(2):169-74. 
25. Filippucci E, Aydin SZ, Karadag O, Salaffi F, Gutierrez M, Direskeneli H, et al. Reliability of 
high-resolution ultrasonography in the assessment of Achilles tendon enthesopathy in seronegative 
spondyloarthropathies. Ann Rheum Dis. 2009;68(12):1850-5. 
26. Iagnocco A, Riente L, Delle Sedie A, Filippucci E, Salaffi F, Meenagh G, et al. Ultrasound 
imaging for the rheumatologist. XXII. Achilles tendon involvement in spondyloarthritis. A multi-centre 
study using high frequency volumetric probe. Clin Exp Rheumatol. 2009;27(4):547-51. 
27. McGonagle D, Marzo-Ortega H, O'Connor P, Gibbon W, Hawkey P, Henshaw K, et al. 
Histological assessment of the early enthesitis lesion in spondyloarthropathy. Ann Rheum Dis. 
2002;61(6):534-7. 
28. McGonagle D, Lories RJ, Tan AL, Benjamin M. The concept of a "synovio-entheseal complex" 
and its implications for understanding joint inflammation and damage in psoriatic arthritis and beyond. 
Arthritis Rheum. 2007;56(8):2482-91. 
 149
29. Benjamin M, Toumi H, Suzuki D, Redman S, Emery P, McGonagle D. Microdamage and altered 
vascularity at the enthesis-bone interface provides an anatomic explanation for bone involvement in the 
HLA-B27-associated spondylarthritides and allied disorders. Arthritis Rheum. 2007;56(1):224-33. 
30. Schmidt WA, Schmidt H, Schicke B, Gromnica-Ihle E. Standard reference values for 
musculoskeletal ultrasonography. Ann Rheum Dis. 2004;63(8):988-94. 
31. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing 
spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27(4):361-8. 
32. Feldtkeller E, Khan MA, van der Heijde D, van der Linden S, Braun J. Age at disease onset and 
diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int. 
2003;23(2):61-6. 
33. Collantes E, Zarco P, Munoz E, Juanola X, Mulero J, Fernandez-Sueiro JL, et al. Disease pattern 
of spondyloarthropathies in Spain: description of the first national registry (REGISPONSER) extended 
report. Rheumatology (Oxford). 2007;46(8):1309-15. 
34. Rudwaleit M, van der Heijde D, Landewe R, Listing J, Akkoc N, Brandt J, et al. The 
development of Assessment of SpondyloArthritis international Society classification criteria for axial 
spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68(6):777-83. 
35. D'Agostino MA, Aegerter P, Bechara K, Salliot C, Judet O, Chimenti MS, et al. How to 
diagnose spondyloarthritis early? Accuracy of peripheral enthesitis detection by power Doppler 
ultrasonography. Ann Rheum Dis. 2011;70(8):1433-40. 
36. de Miguel E, Munoz-Fernandez S, Castillo C, Cobo-Ibanez T, Martin-Mola E. Diagnostic 
accuracy of enthesis ultrasound in the diagnosis of early spondyloarthritis. Ann Rheum Dis. 
2011;70(3):434-9. 
37. Arslan H, Sakarya ME, Adak B, Unal O, Sayarlioglu M. Duplex and color Doppler sonographic 
findings in active sacroiliitis. AJR Am J Roentgenol. 1999;173(3):677-80. 
38. Klauser A, Halpern EJ, Frauscher F, Gvozdic D, Duftner C, Springer P, et al. Inflammatory low 
back pain: high negative predictive value of contrast-enhanced color Doppler ultrasound in the detection 
of inflamed sacroiliac joints. Arthritis Rheum. 2005;53(3):440-4. 
39. Unlu E, Pamuk ON, Cakir N. Color and duplex Doppler sonography to detect sacroiliitis and 
spinal inflammation in ankylosing spondylitis. Can this method reveal response to anti-tumor necrosis 
factor therapy? J Rheumatol. 2007;34(1):110-6. 
40. Spadaro A, Iagnocco A, Baccano G, Ceccarelli F, Sabatini E, Valesini G. Sonographic-detected 
joint effusion compared with physical examination in the assessment of sacroiliac joints in 
spondyloarthritis. Ann Rheum Dis. 2009;68(10):1559-63. 
41. Klauser AS, De Zordo T, Bellmann-Weiler R, Feuchtner GM, Sailer-Hock M, Sogner P, et al. 
Feasibility of second-generation ultrasound contrast media in the detection of active sacroiliitis. Arthritis 
Rheum. 2009;61(7):909-16. 
42. Hu Y, Zhu J, Xue Q, Wang N, Hu B. Scanning of the sacroiliac joint and entheses by color 
Doppler ultrasonography in patients with ankylosing spondylitis. J Rheumatol. 2011;38(8):1651-5. 
43. Zhu J, Xing C, Jiang Y, Hu Y, Hu B, Wang N. Evaluation of complex appearance in vascularity 
of sacroiliac joint in ankylosing spondylitis by color Doppler ultrasonography. Rheumatol Int. 
2012;32(1):69-72. 
44. Baran R. The burden of nail psoriasis: an introduction. Dermatology. 2010;221 Suppl 1:1-5. 
 150
45. de Jong EM, Seegers BA, Gulinck MK, Boezeman JB, van de Kerkhof PC. Psoriasis of the nails 
associated with disability in a large number of patients: results of a recent interview with 1,728 patients. 
Dermatology. 1996;193(4):300-3. 
46. Wilson FC, Icen M, Crowson CS, McEvoy MT, Gabriel SE, Kremers HM. Incidence and 
clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis 
Rheum. 2009;61(2):233-9. 
47. Jones SM, Armas JB, Cohen MG, Lovell CR, Evison G, McHugh NJ. Psoriatic arthritis: 
outcome of disease subsets and relationship of joint disease to nail and skin disease. Br J Rheumatol. 
1994;33(9):834-9. 
48. Williamson L, Dalbeth N, Dockerty JL, Gee BC, Weatherall R, Wordsworth BP. Extended 
report: nail disease in psoriatic arthritis--clinically important, potentially treatable and often overlooked. 
Rheumatology (Oxford). 2004;43(6):790-4. 
49. McGonagle D, Tan AL, Benjamin M. The nail as a musculoskeletal appendage--implications for 
an improved understanding of the link between psoriasis and arthritis. Dermatology. 2009;218(2):97-102. 
50. Tan AL, Benjamin M, Toumi H, Grainger AJ, Tanner SF, Emery P, et al. The relationship 
between the extensor tendon enthesis and the nail in distal interphalangeal joint disease in psoriatic 
arthritis--a high-resolution MRI and histological study. Rheumatology (Oxford). 2007;46(2):253-6. 
51. Tan AL, Toumi H, Benjamin M, Grainger AJ, Tanner SF, Emery P, et al. Combined high-
resolution magnetic resonance imaging and histological examination to explore the role of ligaments and 
tendons in the phenotypic expression of early hand osteoarthritis. Ann Rheum Dis. 2006;65(10):1267-72. 
52. Ash ZR, Tinazzi I, Gallego CC, Kwok C, Wilson C, Goodfield M, et al. Psoriasis patients with 
nail disease have a greater magnitude of underlying systemic subclinical enthesopathy than those with 
normal nails. Ann Rheum Dis. 2012;71(4):553-6. 
53. Cassell SE, Bieber JD, Rich P, Tutuncu ZN, Lee SJ, Kalunian KC, et al. The modified Nail 
Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with 
psoriatic arthritis. J Rheumatol. 2007;34(1):123-9. 
54. Rich P, Scher RK. Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis. J 
Am Acad Dermatol. 2003;49(2):206-12. 
55. Aydin SZ, Ash Z, Del Galdo F, Marzo-Ortega H, Wakefield RJ, Emery P, et al. Optical 
coherence tomography: a new tool to assess nail disease in psoriasis? Dermatology. 2011;222(4):311-3. 
56. Gutierrez M, Wortsman X, Filippucci E, De Angelis R, Filosa G, Grassi W. High-frequency 
sonography in the evaluation of psoriasis: nail and skin involvement. J Ultrasound Med. 
2009;28(11):1569-74. 
57. Mogensen M, Thomsen JB, Skovgaard LT, Jemec GB. Nail thickness measurements using 
optical coherence tomography and 20-MHz ultrasonography. Br J Dermatol. 2007;157(5):894-900. 
58. Soscia E, Scarpa R, Cimmino MA, Atteno M, Peluso R, Sirignano C, et al. Magnetic resonance 
imaging of nail unit in psoriatic arthritis. J Rheumatol Suppl. 2009;83:42-5. 
59. Gladman DD, Shuckett R, Russell ML, Thorne JC, Schachter RK. Psoriatic arthritis (PSA)--an 
analysis of 220 patients. Q J Med. 1987;62(238):127-41. 
60. Jiaravuthisan MM, Sasseville D, Vender RB, Murphy F, Muhn CY. Psoriasis of the nail: 
anatomy, pathology, clinical presentation, and a review of the literature on therapy. J Am Acad Dermatol. 
2007;57(1):1-27. 
 151
61. Love TJ, Gudbjornsson B, Gudjonsson JE, Valdimarsson H. Psoriatic arthritis in Reykjavik, 
Iceland: prevalence, demographics, and disease course. J Rheumatol. 2007;34(10):2082-8. 
62. Aydin SZ, Ash ZR, Tinazzi I, Castillo-Gallego C, Kwok C, Wilson C, et al. The link between 
enthesitis and arthritis in psoriatic arthritis: a switch to a vascular phenotype at insertions may play a role 
in arthritis development. Ann Rheum Dis. 2013;72(6):992-5. 
63. McGonagle D, Conaghan PG, Emery P. Psoriatic arthritis: a unified concept twenty years on. 
Arthritis Rheum. 1999;42(6):1080-6. 
64. McGonagle D, Gibbon W, Emery P. Classification of inflammatory arthritis by enthesitis. 
Lancet. 1998;352(9134):1137-40. 
65. Aydin SZ, Castillo-Gallego C, Ash ZR, Marzo-Ortega H, Emery P, Wakefield RJ, et al. 
Ultrasonographic assessment of nail in psoriatic disease shows a link between onychopathy and distal 
interphalangeal joint extensor tendon enthesopathy. Dermatology. 2012;225(3):231-5. 
66. Kyriakou A, Patsatsi A, Sotiriadis D. Detailed analysis of specific nail psoriasis features and 
their correlations with clinical parameters: a cross-sectional study. Dermatology. 2011;223(3):222-9. 
67. Palmou N, Marzo-Ortega H, Ash Z, Goodfield M, Coates LC, Helliwell PS, et al. Linear pitting 
and splinter haemorrhages are more commonly seen in the nails of patients with established psoriasis in 
comparison to psoriatic arthritis. Dermatology. 2011;223(4):370-3. 
68. Scarpa R, Soscia E, Peluso R, Atteno M, Manguso F, Del Puente A, et al. Nail and distal 
interphalangeal joint in psoriatic arthritis. J Rheumatol. 2006;33(7):1315-9. 
69. Tan AL, Grainger AJ, Tanner SF, Emery P, McGonagle D. A high-resolution magnetic 
resonance imaging study of distal interphalangeal joint arthropathy in psoriatic arthritis and osteoarthritis: 
are they the same? Arthritis Rheum. 2006;54(4):1328-33. 
70. Wollina U, Berger M, Karte K. Calculation of nail plate and nail matrix parameters by 20 MHz 
ultrasound in healthy volunteers and patients with skin disease. Skin Res Technol. 2001;7(1):60-4. 
71. Wortsman X, Gutierrez M, Saavedra T, Honeyman J. The role of ultrasound in rheumatic skin 
and nail lesions: a multi-specialist approach. Clin Rheumatol. 2011;30(6):739-48. 
72. Forsea AM, Carstea EM, Ghervase L, Giurcaneanu C, Pavelescu G. Clinical application of 
optical coherence tomography for the imaging of non-melanocytic cutaneous tumors: a pilot multi-modal 
study. J Med Life. 2010;3(4):381-9. 
73. Pomerantz R, Zell D, McKenzie G, Siegel DM. Optical Coherence Tomography Used as a 
Modality to Delineate Basal Cell Carcinoma prior to Mohs Micrographic Surgery. Case Rep Dermatol. 
2011;3(3):212-8. 
74. Coleman AJ, Richardson TJ, Orchard G, Uddin A, Choi MJ, Lacy KE. Histological correlates of 
optical coherence tomography in non-melanoma skin cancer. Skin Res Technol. 2013;19(1):10-9. 
75. Cunha D, Richardson T, Sheth N, Orchard G, Coleman A, Mallipeddi R. Comparison of ex vivo 
optical coherence tomography with conventional frozen-section histology for visualizing basal cell 
carcinoma during Mohs micrographic surgery. Br J Dermatol. 2011;165(3):576-80. 
76. Schuman JS, Hee MR, Arya AV, Pedut-Kloizman T, Puliafito CA, Fujimoto JG, et al. Optical 
coherence tomography: a new tool for glaucoma diagnosis. Curr Opin Ophthalmol. 1995;6(2):89-95. 
77. Leitgeb R, Hitzenberger C, Fercher A. Performance of fourier domain vs. time domain optical 
coherence tomography. Opt Express. 2003;11(8):889-94. 
 152
78. Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and 
treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol. 
2005;141(12):1537-41. 
79. Radtke MA, Reich K, Blome C, Rustenbach S, Augustin M. Prevalence and clinical features of 
psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national 
survey. J Eur Acad Dermatol Venereol. 2009;23(6):683-91. 
80. Reich K, Kruger K, Mossner R, Augustin M. Epidemiology and clinical pattern of psoriatic 
arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-
type psoriasis. Br J Dermatol. 2009;160(5):1040-7. 
81. Christophers E, Barker JN, Griffiths CE, Dauden E, Milligan G, Molta C, et al. The risk of 
psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in 
European dermatology clinics. J Eur Acad Dermatol Venereol. 2010;24(5):548-54. 
82. McGonagle D, Gibbon W, O'Connor P, Green M, Pease C, Emery P. Characteristic magnetic 
resonance imaging entheseal changes of knee synovitis in spondylarthropathy. Arthritis Rheum. 
1998;41(4):694-700. 
83. Gisondi P, Tinazzi I, El-Dalati G, Gallo M, Biasi D, Barbara LM, et al. Lower limb enthesopathy 
in patients with psoriasis without clinical signs of arthropathy: a hospital-based case-control study. Ann 
Rheum Dis. 2008;67(1):26-30. 
84. McGonagle D, Ash Z, Dickie L, McDermott M, Aydin SZ. The early phase of psoriatic arthritis. 
Ann Rheum Dis. 2011;70 Suppl 1:i71-6. 
85. Wakefield RJ, Green MJ, Marzo-Ortega H, Conaghan PG, Gibbon WW, McGonagle D, et al. 
Should oligoarthritis be reclassified? Ultrasound reveals a high prevalence of subclinical disease. Ann 
Rheum Dis. 2004;63(4):382-5. 
86. Kurosaka D, Hirai K, Nishioka M, Miyamoto Y, Yoshida K, Noda K, et al. Clinical significance 
of serum levels of vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in patients with 
rheumatoid arthritis. J Rheumatol. 2010;37(6):1121-8. 
87. Naredo E, Moller I, Cruz A, Carmona L, Garrido J. Power Doppler ultrasonographic monitoring 
of response to anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. Arthritis Rheum. 
2008;58(8):2248-56. 
88. Aydin SZ, Karadag O, Filippucci E, Atagunduz P, Akdogan A, Kalyoncu U, et al. Monitoring 
Achilles enthesitis in ankylosing spondylitis during TNF-alpha antagonist therapy: an ultrasound study. 
Rheumatology (Oxford). 2010;49(3):578-82. 
89. Fournie B, Margarit-Coll N, Champetier de Ribes TL, Zabraniecki L, Jouan A, Vincent V, et al. 
Extrasynovial ultrasound abnormalities in the psoriatic finger. Prospective comparative power-doppler 
study versus rheumatoid arthritis. Joint Bone Spine. 2006;73(5):527-31. 
90. Gutierrez M, Filippucci E, Salaffi F, Di Geso L, Grassi W. Differential diagnosis between 
rheumatoid arthritis and psoriatic arthritis: the value of ultrasound findings at metacarpophalangeal joints 
level. Ann Rheum Dis. 2011;70(6):1111-4. 
91. Gutierrez M, Filippucci E, De Angelis R, Salaffi F, Filosa G, Ruta S, et al. Subclinical entheseal 
involvement in patients with psoriasis: an ultrasound study. Semin Arthritis Rheum. 2011;40(5):407-12. 
92. Green M, Marzo-Ortega H, Wakefield RJ, Astin P, Proudman S, Conaghan PG, et al. Predictors 
of outcome in patients with oligoarthritis: results of a protocol of intraarticular corticosteroids to all 
clinically active joints. Arthritis Rheum. 2001;44(5):1177-83. 
 153
93. Marzo-Ortega H, Green MJ, Keenan AM, Wakefield RJ, Proudman S, Emery P. A randomized 
controlled trial of early intervention with intraarticular corticosteroids followed by sulfasalazine versus 
conservative treatment in early oligoarthritis. Arthritis Rheum. 2007;57(1):154-60. 
94. Kvien TK, Glennas A, Melby K, Granfors K, Andrup O, Karstensen B, et al. Reactive arthritis: 
incidence, triggering agents and clinical presentation. J Rheumatol. 1994;21(1):115-22. 
95. Parker JD, Capell HA. An acute arthritis clinic--one year's experience. Br J Rheumatol. 
1986;25(3):293-5. 
96. Egsmose C, Hansen TM, Andersen LS, Beier JM, Christensen L, Ejstrup L, et al. Limited effect 
of sulphasalazine treatment in reactive arthritis. A randomised double blind placebo controlled trial. Ann 
Rheum Dis. 1997;56(1):32-6. 
97. Glennas A, Kvien TK, Melby K, Refvem OK, Andrup O, Karstensen B, et al. Acute sarcoid 
arthritis: occurrence, seasonal onset, clinical features and outcome. Br J Rheumatol. 1995;34(1):45-50. 
98. Toivanen A. Managing reactive arthritis. Rheumatology (Oxford). 2000;39(2):117-9. 
99. Richette P, Tubach F, Breban M, Viguier M, Bachelez H, Bardin T, et al. Psoriasis and 
phenotype of patients with early inflammatory back pain. Ann Rheum Dis. 2013;72(4):566-71. 
100. Gong Y, Zheng N, Chen SB, Xiao ZY, Wu MY, Liu Y, et al. Ten years' experience with needle 
biopsy in the early diagnosis of sacroiliitis. Arthritis Rheum. 2012;64(5):1399-406. 
101. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to 
defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity 
Index. J Rheumatol. 1994;21(12):2286-91. 
102. Lukas C, Landewe R, Sieper J, Dougados M, Davis J, Braun J, et al. Development of an ASAS-
endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis. 
2009;68(1):18-24. 
103. Nazarian LN, Rawool NM, Martin CE, Schweitzer ME. Synovial fluid in the hindfoot and ankle: 
detection of amount and distribution with US. Radiology. 1995;197(1):275-8. 
104. de Miguel E, Falcao S, Castillo C, Plasencia C, Garcia M, Branco JC, et al. Enthesis erosion in 
spondyloarthritis is not a persistent structural lesion. Ann Rheum Dis. 2011;70(11):2008-10. 
105. Naredo E, Batlle-Gualda E, Garcia-Vivar ML, Garcia-Aparicio AM, Fernandez-Sueiro JL, 
Fernandez-Prada M, et al. Power Doppler ultrasonography assessment of entheses in 
spondyloarthropathies: response to therapy of entheseal abnormalities. J Rheumatol. 2010;37(10):2110-7. 
106. Baraliakos X, van den Berg R, Braun J, van der Heijde D. Update of the literature review on 
treatment with biologics as a basis for the first update of the ASAS/EULAR management 
recommendations of ankylosing spondylitis. Rheumatology (Oxford). 2012;51(8):1378-87. 
107. van der Heijde D, Lie E, Kvien TK, Sieper J, Van den Bosch F, Listing J, et al. ASDAS, a highly 
discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum 
Dis. 2009;68(12):1811-8. 
108. van der Heijde D, Calin A, Dougados M, Khan MA, van der Linden S, Bellamy N. Selection of 
instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in 
ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing 
Spondylitis. J Rheumatol. 1999;26(4):951-4. 
 154
109. van der Wurff P, Hagmeijer RH, Meyne W. Clinical tests of the sacroiliac joint. A systematic 
methodological review. Part 1: Reliability. Man Ther. 2000;5(1):30-6. 
110. Appel H, Loddenkemper C, Grozdanovic Z, Ebhardt H, Dreimann M, Hempfing A, et al. 
Correlation of histopathological findings and magnetic resonance imaging in the spine of patients with 
ankylosing spondylitis. Arthritis Res Ther. 2006;8(5):R143. 
111. Klauser AS, Sailer-Hoeck M, Abdellah MM, Taljanovic MS, Siedentopf C, Auer T, et al. 
Feasibility of Ultrasound-Guided Sacroiliac Joint Injections in Children Presenting with Sacroiliitis. 
Ultraschall Med. 2016;37(4):393-8. 
112. Hu Z, Xu M, Wang Q, Qi J, Lv Q, Gu J. Colour Doppler ultrasonography can be used to detect 
the changes of sacroiliitis and peripheral enthesitis in patients with ankylosing spondylitis during 
adalimumab treatment. Clin Exp Rheumatol. 2015;33(6):844-50. 
113. Sattler E, Kaestle R, Rothmund G, Welzel J. Confocal laser scanning microscopy, optical 
coherence tomography and transonychial water loss for in vivo investigation of nails. Br J Dermatol. 
2012;166(4):740-6. 
114. Abuzahra F, Spoler F, Forst M, Brans R, Erdmann S, Merk HF, et al. Pilot study: optical 
coherence tomography as a non-invasive diagnostic perspective for real time visualisation of 
onychomycosis. Mycoses. 2010;53(4):334-9. 
115. Rothmund G, Sattler EC, Kaestle R, Fischer C, Haas CJ, Starz H, et al. Confocal laser scanning 
microscopy as a new valuable tool in the diagnosis of onychomycosis - comparison of six diagnostic 
methods. Mycoses. 2013;56(1):47-55. 
116. Reece RJ, Canete JD, Parsons WJ, Emery P, Veale DJ. Distinct vascular patterns of early 
synovitis in psoriatic, reactive, and rheumatoid arthritis. Arthritis Rheum. 1999;42(7):1481-4. 
117. Fearon U, Griosios K, Fraser A, Reece R, Emery P, Jones PF, et al. Angiopoietins, growth 
factors, and vascular morphology in early arthritis. J Rheumatol. 2003;30(2):260-8. 
118. Zaric D, Clemmensen OJ, Worm AM, Stahl D. Capillary microscopy of the nail fold in patients 
with psoriasis and psoriatic arthritis. Dermatologica. 1982;164(1):10-4. 
119. Creamer D, Allen MH, Sousa A, Poston R, Barker JN. Localization of endothelial proliferation 
and microvascular expansion in active plaque psoriasis. Br J Dermatol. 1997;136(6):859-65. 
120. Naredo E, Moller I, de Miguel E, Batlle-Gualda E, Acebes C, Brito E, et al. High prevalence of 
ultrasonographic synovitis and enthesopathy in patients with psoriasis without psoriatic arthritis: a 
prospective case-control study. Rheumatology (Oxford). 2011;50(10):1838-48. 
121. Tinazzi I, McGonagle D, Biasi D, Confente S, Caimmi C, Girolomoni G, et al. Preliminary 
evidence that subclinical enthesopathy may predict psoriatic arthritis in patients with psoriasis. J 
Rheumatol. 2011;38(12):2691-2. 
122. Sampaio-Barros PD, Bortoluzzo AB, Conde RA, Costallat LT, Samara AM, Bertolo MB. 
Undifferentiated spondyloarthritis: a longterm followup. J Rheumatol. 2010;37(6):1195-9. 
123. Huerta-Sil G, Casasola-Vargas JC, Londono JD, Rivas-Ruiz R, Chavez J, Pacheco-Tena C, et al. 
Low grade radiographic sacroiliitis as prognostic factor in patients with undifferentiated spondyloarthritis 
fulfilling diagnostic criteria for ankylosing spondylitis throughout follow up. Ann Rheum Dis. 
2006;65(5):642-6. 
124. Kumar A, Bansal M, Srivastava DN, Pandhi A, Menon A, Mehra NK, et al. Long-term outcome 
of undifferentiated spondylarthropathy. Rheumatol Int. 2001;20(6):221-4. 
 155
125. Nordal E, Zak M, Aalto K, Berntson L, Fasth A, Herlin T, et al. Ongoing disease activity and 
changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis. Arthritis Rheum. 
2011;63(9):2809-18. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
